Q3 2024 --06-30 false 0000050471 False False False False 0 0 3 00000504712023-07-012024-03-31 thunderdome:item 00000504712024-01-012024-03-31 iso4217:USD 0000050471trak:SeriesB1PreferredStockMember2023-07-012024-03-31 0000050471us-gaap:ServiceAgreementsMembertrak:FMIMember2022-07-012023-03-31 0000050471us-gaap:ServiceAgreementsMembertrak:FMIMember2023-07-012024-03-31 0000050471us-gaap:RelatedPartyMember2023-06-30 0000050471us-gaap:RelatedPartyMember2024-03-31 00000504712024-03-31 xbrli:shares iso4217:USDxbrli:shares 0000050471trak:ShareRepurchaseProgramMember2023-12-31 0000050471trak:ShareRepurchaseProgramMember2023-10-012023-12-31 00000504712023-10-012023-12-31 0000050471trak:ShareRepurchaseProgramMember2023-09-30 0000050471trak:ShareRepurchaseProgramMember2023-07-012023-09-30 00000504712023-07-012023-09-30 00000504712019-05-202024-03-31 00000504712022-05-102022-05-10 00000504712021-08-312021-08-31 00000504712021-08-31 00000504712021-05-18 00000504712021-05-182021-05-18 00000504712019-05-09 0000050471trak:SeriesB1PreferredStockMember2024-03-31 0000050471trak:SeriesB1PreferredStockMember2024-01-012024-03-31 0000050471trak:SeriesB1PreferredStockMember2023-12-31 0000050471trak:SeriesB1PreferredStockMember2023-10-012023-12-31 0000050471trak:SeriesB1PreferredStockMember2023-09-30 0000050471trak:SeriesB1PreferredStockMember2023-07-012023-09-30 0000050471us-gaap:SeriesBPreferredStockMember2023-12-31 0000050471us-gaap:SeriesBPreferredStockMember2023-07-012023-12-31 0000050471us-gaap:SeriesBPreferredStockMember2024-03-31 0000050471trak:SeriesBAndSeriesB1PreferredStockMember2023-12-31 0000050471trak:SeriesBAndSeriesB1PreferredStockMember2023-10-012023-12-31 0000050471trak:SeriesBAndSeriesB1PreferredStockMember2023-09-30 0000050471trak:SeriesBAndSeriesB1PreferredStockMember2023-07-012023-09-30 00000504712012-01-012024-03-31 00000504712023-08-29 xbrli:pure 0000050471us-gaap:SeriesBPreferredStockMember2024-01-012024-03-31 0000050471trak:BlankCheckMember2024-03-31 utr:Y 0000050471trak:ExercisePriceTenDollarsMaximumMember2024-01-012024-03-31 0000050471trak:ExercisePriceTenDollarsMaximumMember2024-03-31 0000050471trak:ExercisePriceFourDollarsMinimumMember2024-01-012024-03-31 0000050471trak:ExercisePriceFourDollarsMinimumMember2024-03-31 0000050471us-gaap:RestrictedStockUnitsRSUMembertrak:VestedAndUnissuedMember2024-03-31 0000050471us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2024-03-31 0000050471us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2024-01-012024-03-31 0000050471us-gaap:ShareBasedPaymentArrangementNonemployeeMember2024-01-012024-03-31 0000050471us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2023-12-31 00000504712022-07-012023-03-31 00000504712023-01-012023-03-31 0000050471srt:MaximumMember2023-03-31 0000050471srt:MaximumMember2024-03-31 0000050471trak:ProfessionalServicesMember2022-07-012023-03-31 0000050471trak:ProfessionalServicesMember2023-07-012024-03-31 0000050471trak:ProfessionalServicesMember2023-01-012023-03-31 0000050471trak:ProfessionalServicesMember2024-01-012024-03-31 0000050471trak:SubscriptionAndSupportMember2022-07-012023-03-31 0000050471trak:SubscriptionAndSupportMember2023-07-012024-03-31 0000050471trak:SubscriptionAndSupportMember2023-01-012023-03-31 0000050471trak:SubscriptionAndSupportMember2024-01-012024-03-31 00000504712023-06-30 00000504712023-03-31 0000050471us-gaap:RetainedEarningsMember2023-03-31 0000050471us-gaap:AdditionalPaidInCapitalMember2023-03-31 0000050471us-gaap:CommonStockMember2023-03-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-03-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-03-31 0000050471us-gaap:RetainedEarningsMember2023-01-012023-03-31 0000050471us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-31 0000050471us-gaap:CommonStockMember2023-01-012023-03-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-01-012023-03-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-01-012023-03-31 00000504712022-12-31 0000050471us-gaap:RetainedEarningsMember2022-12-31 0000050471us-gaap:AdditionalPaidInCapitalMember2022-12-31 0000050471us-gaap:CommonStockMember2022-12-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2022-12-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2022-12-31 00000504712022-10-012022-12-31 0000050471us-gaap:RetainedEarningsMember2022-10-012022-12-31 0000050471us-gaap:AdditionalPaidInCapitalMember2022-10-012022-12-31 0000050471us-gaap:CommonStockMember2022-10-012022-12-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2022-10-012022-12-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2022-10-012022-12-31 00000504712022-09-30 0000050471us-gaap:RetainedEarningsMember2022-09-30 0000050471us-gaap:AdditionalPaidInCapitalMember2022-09-30 0000050471us-gaap:CommonStockMember2022-09-30 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2022-09-30 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2022-09-30 00000504712022-07-012022-09-30 0000050471us-gaap:RetainedEarningsMember2022-07-012022-09-30 0000050471us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-30 0000050471us-gaap:CommonStockMember2022-07-012022-09-30 00000504712022-06-30 0000050471us-gaap:RetainedEarningsMember2022-06-30 0000050471us-gaap:AdditionalPaidInCapitalMember2022-06-30 0000050471us-gaap:CommonStockMember2022-06-30 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2022-06-30 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2022-06-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-31 0000050471us-gaap:RetainedEarningsMember2024-03-31 0000050471us-gaap:AdditionalPaidInCapitalMember2024-03-31 0000050471us-gaap:CommonStockMember2024-03-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2024-03-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2024-03-31 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-31 0000050471us-gaap:RetainedEarningsMember2024-01-012024-03-31 0000050471us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2024-01-012024-03-31 0000050471us-gaap:CommonStockMember2024-01-012024-03-31 00000504712023-12-31 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-31 0000050471us-gaap:RetainedEarningsMember2023-12-31 0000050471us-gaap:AdditionalPaidInCapitalMember2023-12-31 0000050471us-gaap:CommonStockMember2023-12-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-12-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-12-31 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-31 0000050471us-gaap:RetainedEarningsMember2023-10-012023-12-31 0000050471us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-31 0000050471us-gaap:CommonStockMember2023-10-012023-12-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-10-012023-12-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-10-012023-12-31 00000504712023-09-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-30 0000050471us-gaap:RetainedEarningsMember2023-09-30 0000050471us-gaap:AdditionalPaidInCapitalMember2023-09-30 0000050471us-gaap:CommonStockMember2023-09-30 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-09-30 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-09-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-30 0000050471us-gaap:RetainedEarningsMember2023-07-012023-09-30 0000050471us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-30 0000050471us-gaap:CommonStockMember2023-07-012023-09-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-30 0000050471us-gaap:RetainedEarningsMember2023-06-30 0000050471us-gaap:AdditionalPaidInCapitalMember2023-06-30 0000050471us-gaap:CommonStockMember2023-06-30 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-06-30 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-06-30 0000050471trak:CommonStockToPayAccruedLiabilitiesMember2022-07-012023-03-31 0000050471trak:CommonStockToPayAccruedLiabilitiesMember2023-07-012024-03-31 0000050471trak:SeriesB1PreferredStockMember2023-06-30 0000050471us-gaap:SeriesBPreferredStockMember2023-06-30 0000050471us-gaap:CustomerRelationshipsMember2023-06-30 0000050471us-gaap:CustomerRelationshipsMember2024-03-31 00000504712024-05-15
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended March 31, 2024

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from              to                .

 

Commission File Number 001-34941

 

REPOSITRAK, INC.

(Exact name of small business issuer as specified in its charter)

 

Nevada

37-1454128

(State or other jurisdiction of incorporation or organization)

(IRS Employer Identification No.)

 

5282 South Commerce Drive, Suite D292, Murray, Utah 84107

(Address of principal executive offices)

 

(435) 645-2000

(Registrant’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which

registered

Common stock, par value $0.01 per share

TRAK

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒
   

Emerging growth company

☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes  ☒ No

 

As of May15, 2024, 18,223,893 shares of the registrant’s common stock, $0.01 par value, were issued and outstanding.  

 

 
 

 

 

REPOSITRAK, INC.

 

TABLE OF CONTENTS

 

   

Page

PART I - FINANCIAL INFORMATION
     

Item 1.

Financial Statements

 1
     
 

Consolidated Condensed Balance Sheets as of March 31, 2024 and June 30, 2023 (Unaudited)

 1
 

Consolidated Condensed Statements of Operations and Comprehensive Income for the Three and Nine months Ended March 31, 2024 and 2023 (Unaudited)

 2
 

Consolidated Condensed Statements of Cash Flows for the Nine months Ended March 31, 2024 and 2023 (Unaudited)

 3
 

Consolidated Condensed Statements of Stockholders’ Equity for the Three and Nine months Ended March 31, 2024 and 2023 (Unaudited)

 4
 

Notes to Consolidated Condensed Financial Statements

 6
     

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

 14
     

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 24
     

Item 4.

Controls and Procedures

 25
     

PART II OTHER INFORMATION
     

Item 1.

Legal Proceedings

 26
     

Item 1A.

Risk Factors

 26
     

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 26
     

Item 3.

Defaults Upon Senior Securities

 26
     

Item 5.

Other Information

 26
     

Item 6.

Exhibits

 26
     

Signatures

 27

 

 
 
 

 

 

PART I

 

FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS

 

REPOSITRAK, INC.

Consolidated Condensed Balance Sheets (Unaudited)

 

   

March 31,

2024

    

June 30,

2023

  

Assets

                

Current Assets

                

Cash and cash equivalents

   $ 24,452,680     $ 23,990,879  

Receivables, net of allowance for doubtful accounts of $226,198 and $170,103 at March 31, 2024 and June 30, 2023, respectively

     3,776,472       2,523,019  

Contract asset – unbilled current portion

     147,520       186,959  

Prepaid expense and other current assets

     451,041       573,763  

Total Current Assets

     28,827,713       27,274,620  
                 

Property and Equipment, net

     591,724       986,300  
                 

Other Assets:

                

Deposits and other assets

     22,414       22,414  

Prepaid expense – less current portion

     6,677       36,282  

Contract asset – unbilled long-term portion

     108,052       108,052  

Operating lease – right-of-use asset

     265,726       310,796  

Customer relationships

     164,250       262,800  

Goodwill

     20,883,886       20,883,886  

Capitalized software costs, net

     463,036       698,281  

Total Other Assets

     21,914,041       22,322,511  
                 

Total Assets

   $ 51,333,478     $ 50,583,431  
                 

Liabilities and Shareholders’ Equity

                

Current Liabilities

                

Accounts payable

   $ 510,412     $ 431,387  

Accrued liabilities

     1,390,232       1,620,000  

Contract liability – deferred revenue

     2,466,262       1,903,001  

Operating lease liability – current

     62,725       58,771  

Notes payable and financing leases – current

     215,274       219,262  

Total Current Liabilities

     4,644,905       4,232,421  
                 

Long-Term Liabilities

                

Operating lease liability – less current portion

     215,676       263,047  

Notes payable and financing leases – less current portion

     -       206,032  

Total Liabilities

     4,860,581       4,701,500  
                 

Commitments and Contingencies

            
                 

Stockholders’ Equity:

                

Preferred Stock; $0.01 par value, 30,000,000 shares authorized;

                

Series B Preferred, 700,000 shares authorized; 625,375 shares issued and outstanding at March 31, 2024 and June 30, 2023;

     6,254       6,254  

Series B-1 Preferred, 550,000 shares authorized; 72,216 and 212,402 shares issued and outstanding at March 31, 2024 and June 30, 2023, respectively

     722       2,124  

Common Stock, $0.01 par value, 50,000,000 shares authorized; 18,221,527 and 18,309,051 issued and outstanding at March 31, 2024 and June 30, 2023, respectively

     182,218       183,093  

Additional paid-in capital

     65,277,419       67,732,887  

Accumulated other comprehensive loss

     (31,006

)

     -  

Accumulated deficit

     (18,962,710

)

     (22,042,427

)

Total Stockholders’ Equity

     46,472,897       45,881,931  

Total Liabilities and Stockholders’ Equity

   $ 51,333,478     $ 50,583,431  

 

See accompanying notes to consolidated condensed financial statements.

 

- 1 -
 

 

 

REPOSITRAK, INC.

Consolidated Condensed Statements of Operations and Comprehensive Income (Unaudited)

 

   

Three Months Ended

March 31,

   

Nine Months Ended

March 31,

  
   

2024

    

2023

    

2024

    

2023

  
                                 

Revenue

   $ 5,084,866     $ 4,824,101     $ 15,270,729     $ 14,295,091  
                                 

Operating expense:

                                

Cost of services and product support

     831,912       840,272       2,571,533       2,539,618  

Sales and marketing

     1,349,838       1,239,946       4,119,716       3,667,017  

General and administrative

     1,352,197       916,237       3,978,798       3,392,056  

Depreciation and amortization

     288,576       305,864       897,479       771,030  

Total operating expense

     3,822,523       3,302,319       11,567,526       10,369,721  
                                 

Income from operations

     1,262,343       1,521,782       3,703,203       3,925,370  
                                 

Other income (expense):

                                

Interest income

     350,691       275,941       925,297       554,299  

Interest expense

     (8,036

)

     (9,771

)

     (21,956

)

     (52,481

)

Unrealized gain (loss) on short term investments

     5,429       35,068       48,071       (3,753 )

Other gain

     -       -       -       70,047  

Income before income taxes

     1,610,427       1,823,020       4,654,615       4,493,482  
                                 

(Provision) for income taxes:

     (60,000

)

     (160,000

)

     (274,491

)

     (280,006

)

Net income

     1,550,427       1,663,020       4,380,124       4,213,476  
                                 

Dividends on preferred stock

     (134,345

)

     (146,611

)

     (427,567

)

     (439,833

)
                                 

Net income applicable to common shareholders

   $ 1,416,082     $ 1,516,409     $ 3,952,557     $ 3,773,643  
                                 

Weighted average shares, basic

     18,194,000       18,394,000       18,194,000       18,408,000  

Weighted average shares, diluted

     18,954,000       18,751,000       18,874,000       18,702,000  

Basic income per share

   $ 0.08     $ 0.08     $ 0.22     $ 0.20  

Diluted income per share

   $ 0.08     $ 0.08     $ 0.21     $ 0.20  

Comprehensive income:

                                

Net income

   $ 1,550,427       1,663,020       4,380,124       4,213,476  

Other comprehensive loss:

                                

Unrealized loss on available-for-sale securities

     (25,102

)

     -       (31,006

)

     -  
                                 

Total comprehensive income

   $ 1,525,325       1,663,020       4,349,118       4,213,476  

 

See accompanying notes to consolidated condensed financial statements.

 

- 2 -
 

 

 

REPOSITRAK, INC.

Consolidated Condensed Statements of Cash Flows (Unaudited)

 

   

Nine months

Ended March 31,

  
   

2024

    

2023

  

Cash flows from operating activities:

                

Net income

   $ 4,380,124     $ 4,213,476  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation and amortization

     897,479       771,030  

Amortization of operating right-of-use asset

     45,070       43,019  

Stock compensation expense

     260,853       315,216  

Bad debt expense

     225,000       1,200,000  

(Increase) decrease in:

                

Accounts receivables

     (1,439,014

)

     86,972  

Long-term receivables, prepaids and other assets

     751       655,391  

Increase (decrease) in:

                

Accounts payable

     79,025       (309,812 )

Operating lease liability

     (43,417

)

     (39,777

)
                 

Accrued liabilities

     (58,391

)

     122,744  

Deferred revenue

     563,261       7,631  

Net cash provided by operating activities

     4,910,741       7,065,890  
                 

Cash flows from investing activities:

                

Purchase of property and equipment

     (17,532

)

     (133,944

)

Capitalization of software costs

     -       (769,243 )

Purchase of marketable securities

     (31,006

)

     -  

Net cash (used in) investing activities

     (48,538 )     (903,187 )
                 

Cash flows from financing activities:

                
Net (decrease) in lines of credit     -       (2,590,907

)

Common Stock buyback/retirement

     (1,515,574

)

     (981,194

)

Redemption of series B-1 preferred

     (1,499,990

)

     -  

Proceeds from employee stock plan

     111,839       92,728  

Dividends paid

     (1,286,657

)

     (993,037

)

Payments on notes payable and capital leases

     (210,020

)

     (209,748 )

Net cash used in financing activities

     (4,400,402 )     (4,682,158 )
                 

Net increase (decrease) in cash and cash equivalents

     461,801       1,480,545  
                 

Cash and cash equivalents at beginning of period

     23,990,879       21,460,948  

Cash and cash equivalents at end of period

   $ 24,452,680     $ 22,941,493  
                 

Supplemental disclosure of cash flow information:

                

Cash paid for income taxes

   $ 317,944     $ 264,486  

Cash paid for interest

   $ 11,711     $ 52,481  

Cash paid for operating leases

   $ 54,606     $ 53,015  
                 

Supplemental disclosure of non-cash investing and financing activities:

                

Common stock to pay accrued liabilities

   $ 445,980     $ 256,977  

Dividends accrued on preferred stock

   $ 427,567     $ 439,833  

 

See accompanying notes to consolidated condensed financial statements.

 

- 3 -
 

 

 

REPOSITRAK, INC.

Consolidated Condensed Statements of Stockholders’ Equity (Deficit) (Unaudited)

 

Nine months Ended March 31, 2024

 

   

Series B

Preferred Stock

    

Series B-1

Preferred Stock

    

Common Stock

    

Additional

Paid-In

    

Accumulated

    Accumulated

Other

Comprehensive

         
   

Shares

    

Amount

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

    

Loss

    

Total

  
                                                                                 

Balance, June 30, 2023

     625,375     $ 6,254       212,402     $ 2,124       18,309,051     $ 183,093     $ 67,732,887     $ (22,042,427 )     -     $ 45,881,931  

Stock issued for:

                                                                                

Accrued compensation

     -       -       -       -       3,716       37       37,463       -       -       37,500  

Employee stock plan

     -       -       -       -       13,326       133       57,610       -       -       57,743  

Stock buyback

     -       -       -       -       (155,025 )     (1,550 )     (1,320,532 )     -       -       (1,322,082 )

Preferred Dividends-Declared

     -       -       -       -       -       -       -       (146,611 )     -       (146,611 )

Common Stock Dividends-Declared

     -       -       -       -       -       -       -       (272,566 )     -       (272,566 )

Net income

     -       -       -       -       -       -       -       1,378,548       -       1,378,548  

Balance, September 30, 2023

     625,375     $ 6,254       212,402     $ 2,124       18,171,068     $ 181,713     $ 66,507,428     $ (21,083,056 )   $ -     $ 45,614,463  

Stock issued for:

                                                                                

Accrued compensation

     -       -       -       -       9,674       97       72,403       -       -       72,500  

Employee stock plan

     -       -       -       -       -       -       -       -       -       -  

Stock buyback

     -       -       -       -       (22,012 )     (220 )     (193,272 )     -       -       (193,492 )

Preferred Stock redemption

     -       -       (70,093 )     (701 )     -       -       (749,294 )     -       -       (749,995 )

Preferred Dividends-Declared

     -       -       -       -       -       -       -       (146,611 )     -       (146,611 )
Common Stock Dividends-Declared     -       -       -       -       -       -       -       (299,619 )     -       (299,619 )

Net income

     -       -       -       -       -       -       -       1,451,149       -       1,451,149  

Other comprehensive loss

     -       -       -       -       -       -       -       -       (5,904 )     (5,904 )

Balance, December 31, 2023

     625,375     $ 6,254       142,309     $ 1,423       18,158,730     $ 181,590     $ 65,637,265     $ (20,078,137 )   $ (5,904 )   $ 45,742,491  

Stock issued for:

                                                                                

Accrued compensation

                                     56,488       565       335,415                       335,980  

Employee stock plan

                                     6,309       63       54,033                       54,096  

Stock buyback

                                                                             -  

Preferred Stock redemption

                     (70,093 )     (701 )                     (749,294 )                     (749,995 )

Preferred Dividends-Declared

                                                             (134,345 )             (134,345 )

Common Stock Dividends-Declared

                                                             (300,655 )             (300,655 )

Net income

                                                             1,550,427               1,550,427  

Other comprehensive loss

                                                                     (25,102 )     (25,102 )

Balance, March 31, 2024

     625,375     $ 6,254       72,216     $ 722       18,221,527     $ 182,218     $ 65,277,419     $ (18,962,710 )   $ (31,006 )   $ 46,472,897  

 

- 4 -
 

 

Nine months Ended March 31, 2023

 

   

Series B

Preferred Stock

    

Series B-1

Preferred Stock

    

Common Stock

    

Additional

Paid-In

    

Accumulated

          
   

Shares

    

Amount

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

     Total  
                                                                         

Balance, June 30, 2022

     625,375     $ 6,254       212,402     $ 2,124       18,460,538     $ 184,608     $ 68,653,361     $ (25,943,287 )   $ 42,903,060  

Stock issued for:

                                                                        

Accrued compensation

     -       -       -       -       15,603       156       76,717       -       76,873  

Employee stock plan

     -       -       -       -       13,064       131       48,772       -       48,903  

Stock buyback

     -       -       -       -       (20,859 )     (209 )     (103,448 )     -       (103,657 )

Preferred Dividends-Declared

     -       -       -       -       -       -       -       (146,611 )     (146,611 )

Common Stock Dividends-Declared

     -       -       -       -       -       -       -       (277,162 )     (277,162 )

Net income

     -       -       -       -       -       -       -       1,285,112       1,285,112  

Balance, September 30, 2022

     625,375     $ 6,254       212,402     $ 2,124       18,468,346     $ 184,686     $ 68,675,402     $ (25,081,948 )   $ 43,786,518  
                                                                         

Stock issued for:

                                                                        

Accrued compensation

     -       -       -       -       14,691       147       75,175       -       75,322  

Stock buyback

     -       -       -       -       (88,741 )     (888 )     (447,378 )     -       (448,266 )

Preferred Dividends-Declared

     -       -       -       -       -       -       -       (146,611 )     (146,611 )

Common Stock Dividends-Declared

     -       -       -       -       -       -       -       (275,914 )     (275,914 )

Net income

     -       -       -       -       -       -       -       1,265,344       1,265,344  

Balance, December 31, 2022

     625,375     $ 6,254       212,402     $ 2,124       18,394,296     $ 183,945     $ 68,303,199     $ (24,239,129 )   $ 44,256,393  
                                                                         

Stock issued for:

                                                                        

Accrued compensation

     -       -       -       -       19,036       190       104,592       -       104,782  

Employee stock plan

     -       -       -       -       11,583       116       43,709       -       43,825  

Stock buyback

     -       -       -       -       (74,150 )     (741 )     (428,530 )     -       (429,271 )

Preferred Dividends-Declared

     -       -       -       -       -       -       -       (146,611 )     (146,611 )

Common Stock Dividends-Declared

     -       -       -       -       -       -       -       (275,261 )     (275,261 )

Net income

     -       -       -       -       -       -       -       1,663,020       1,663,020  

Balance, March 31, 2023

     625,375     $ 6,254       212,402     $ 2,124       18,350,765     $ 183,510     $ 68,022,970     $ (22,997,981 )   $ 45,216,877  

 

See accompanying notes to consolidated condensed financial statements.

 

- 5 -
 

 

REPOSITRAK, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

 

NOTE 1.

OVERVIEW OF OPERATIONS AND BASIS FOR PRESENTATION

 

Overview

 

ReposiTrak, Inc., a Nevada corporation (“ReposiTrak”, “We”, “us”, “our” or the “Company”) is a Software-as-a-Service (“SaaS”) which operates a business-to-business (“B2B”) e-commerce, compliance & traceability, and supply chain management platform that partners with retailers, wholesalers, distributors and their product suppliers to (a) help them manage specific programs, such as out-of-stock management and scan-based trading; (b) reduce risk in their supply chain by managing compliance documents and data; ensure compliance with new regulatory requirements supporting traceability; and (c) improve product ordering and forecasting in order to accelerate sales, control risks, and improve supply chain efficiencies.

 

The Company’s services are grouped in three application suites:

 

 

1.

ReposiTrak Compliance Management (“Compliance”) solutions, which helps the Company’s customers vet suppliers and reduce a company’s potential regulatory, legal, and criminal risk from its supply chain partners by providing a way for them to ensure these suppliers are compliant with food safety regulations, such as the Food Safety Modernization Act of 2011 (“FSMA”);
     
 

2.

ReposiTrak Traceability Network (“Traceability” or “RTN”), which helps the Company’s customers comply with federal regulatory requirements of traceability and provides the lowest cost, easiest to use way to manage the capture and sharing of key data elements (“KDEs”) now required by Section 204d of FSMA 2011 as designated products move through the supply chain at each ‘event’ known as a ‘critical tracking event’ or “CTE”, which includes tracking from farm to shelf; and
     
 

3.

ReposiTrak Supply Chain Solutions (“Supply Chain”), which help the Company’s customers to more efficiently manage various interactions with their suppliers. In other words, it provides customers with greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their supply chain faster and more cost effectively, and it helps them to manage these relationships more efficiently, enhancing revenue while lowering working capital, labor costs and reducing waste.

 

The Company’s services are delivered though proprietary software products designed, developed, marketed, and supported by the Company. These products provide visibility and facilitate improved business processes among all key constituents in the supply chain, starting with the retailer and moving backwards to suppliers and eventually to raw material providers.

 

The Company provides cloud-based applications and services that address e-commerce, supply chain, food safety, compliance and traceability activities. The principal customers for the Company’s products are household name multi-store food retail chains and restaurants including their suppliers, branded food manufacturers, food wholesalers and distributors, and other food service businesses.

 

The Company has a hub and spoke business model. The Company is typically engaged by retailers and wholesalers (“Hubs”), which in turn require their suppliers (“Spokes”) to utilize the Company’s services.

 

On December 21, 2023, the Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc. The Company is incorporated in the State of Nevada and has two principal subsidiaries: PC Group, Inc., a Utah corporation (98.76% owned) (“PCG Utah”) and Park City Group, Inc., a Delaware corporation (100% owned) (“PCG Delaware” and together with PCG Utah, the “Subsidiaries”). All intercompany transactions and balances have been eliminated in the Company’s consolidated financial statements, which contain the operating results of the operations. The Company has no business operations separate from the operations conducted through its Subsidiaries.

 

The Company’s principal executive offices are located at 5282 South Commerce Drive, Suite D292, Murray, Utah 84107. Its telephone number is (435) 645-2000. Its website address is www.repositrak.com.

 

- 6 -
 

 

Basis of Financial Statement Presentation

 

The interim financial information of the Company as of March 31, 2024 and for the three and nine months ended March 31, 2024 is unaudited, and the balance sheet as of June 30, 2023 is derived from audited financial statements. The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial statements. Accordingly, they omit or condense notes and certain other information normally included in financial statements prepared in accordance with U.S. GAAP. The accounting policies followed for quarterly financial reporting conform with the accounting policies disclosed in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended June 30, 2023. In the opinion of management, all adjustments necessary for a fair presentation of the financial information for the interim periods reported have been made. All such adjustments are of a normal recurring nature. The results of operations for the nine months ended March 31, 2024 are not necessarily indicative of the results that can be expected for the fiscal year ending June 30, 2024. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended June 30, 2023.

 

 

NOTE 2.

SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

The financial statements presented herein reflect the consolidated financial position of ReposiTrak, Inc. and our subsidiaries. All inter-company transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that materially affect the amounts reported in the consolidated financial statements. Actual results could differ from these estimates. The methods, estimates, and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results it reports in its financial statements. The U.S. Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as those that are most important to the portrayal of the Company’s financial condition and results and require the Company to make its most difficult and subjective judgments, often because of the need to make estimates of matters that are inherently uncertain. Based on this definition, the Company’s most critical accounting policies include revenue recognition, goodwill, other long-lived asset valuations, income taxes, stock-based compensation, and capitalization of software development costs.

 

Revenue Recognition

 

The Company recognizes revenue as it transfers control of deliverables (products, solutions and services) to its customers in an amount reflecting the consideration to which it expects to be entitled. To recognize revenue, the Company applies the following five step approach: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied. The Company accounts for a contract based on the terms and conditions the parties agree to, if the contract has commercial substance and if collectability of consideration is probable. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience.

 

The Company may enter into arrangements that consist of multiple performance obligations. Such arrangements may include any combination of its deliverables. To the extent a contract includes multiple promised deliverables, the Company applies judgment to determine whether promised deliverables are capable of being distinct and are distinct in the context of the contract. If these criteria are not met, the promised deliverables are accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, the Company allocates consideration among the performance obligations based on their relative standalone selling price. Standalone selling price is the price at which the Company would sell a promised good or service separately to the customer. When not directly observable, the Company typically estimates standalone selling price by using the expected cost plus a margin approach. The Company typically establishes a standalone selling price range for its deliverables, which is reassessed on a periodic basis or when facts and circumstances change.

 

- 7 -
 

 

For performance obligations where control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The selection of the method to measure progress towards completion requires judgment and is based on the nature of the deliverables to be provided. Revenue related to fixed-price contracts for application development and systems integration services, consulting or other technology services is recognized as the service is performed using the output method, under which the total value of revenue is recognized based on each contract’s deliverable(s) as they are completed and when value is transferred to a customer. Revenue related to fixed-price application maintenance, testing and business process services is recognized based on our right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in FASB ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”), paragraph 606-10-55-18 (“ASC 606-10-55-18”).

 

If the Company’s invoicing is not consistent with the value delivered, revenue is recognized as the service is performed based on the method described above. The output method measures the results achieved and value transferred to a customer, which is updated as the project progresses to reflect the latest available information; such estimates and changes in estimates involve the use of judgment. The cumulative impact of any revision in estimates is reflected in the financial reporting period in which the change in estimate becomes known and any anticipated losses on contracts are recognized immediately. Revenue related to fixed-price hosting and infrastructure services is recognized based on the Company’s right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in ASC 606-10-55-18. If the Company’s invoicing is not consistent with value delivered, revenue is recognized on a straight-line basis unless revenue is earned and obligations are fulfilled in a different pattern. The revenue recognition method applied to the types of contracts described above provides the most faithful depiction of performance towards satisfaction of the Company’s performance obligations.

 

Revenue related to the Company’s software license arrangements that do not require significant modification or customization of the underlying software is recognized when the software is delivered as control is transferred at a point in time. For software license arrangements that require significant functionality enhancements or modification of the software, revenue for the software license and related services is recognized as the services are performed in accordance with the methods described above. In software hosting arrangements, the rights provided to the customer, such as ownership of a license, contract termination provisions and the feasibility of the client to operate the software, are considered in determining whether the arrangement includes a license or a service. Revenue related to software maintenance and support is generally recognized on a straight-line basis over the contract period.

 

Management expects that incremental commission fees paid as a result of obtaining a contract are recoverable and therefore the Company capitalized them as contract costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less.

 

Revenue related to transaction-based or volume-based contracts is recognized over the period the services are provided in a manner that corresponds with the value transferred to the customer to-date relative to the remaining services to be provided.

 

From time to time, the Company may enter into arrangements with third party suppliers to resell products or services. In such cases, the Company evaluates whether the Company is the principal (i.e., report revenue on a gross basis) or agent (i.e., report revenue on a net basis). In doing so, the Company first evaluates whether it controls the good or service before it is transferred to the customer. If the Company controls the good or service before it is transferred to the customer, the Company is the principal; if not, the Company is the agent. Determining whether the Company controls the good or service before it is transferred to the customer may require judgment.

 

The Company provides customers with assurance that the related deliverable will function as the parties intended because it complies with agreed-upon specifications. General updates or patch fixes are not considered an additional performance obligation in the contract.

 

Variable consideration is estimated using either the sum of probability weighted amounts in a range of possible consideration amounts (expected value), or the single most likely amount in a range of possible consideration amounts (most likely amount), depending on which method better predicts the amount of consideration to which we may be entitled. The Company includes in the transaction price variable consideration only to the extent it is probable that a significant reversal of revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company’s estimates of variable consideration and determination of whether to include estimated amounts in the transaction price may involve judgment and is based largely on an assessment of its anticipated performance and all information that is reasonably available to the Company.

 

- 8 -
 

 

The Company assesses the timing of the transfer of goods or services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, the Company does not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less. If the difference in timing arises for reasons other than the provision of finance to either the customer or us, no financing component is deemed to exist. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing its services, not to receive or provide financing from or to customers. The Company does not consider set up or transition fees paid upfront by its customers to represent a financing component, as such fees are required to encourage customer commitment to the project and protect us from early termination of the contract.

 

Trade Accounts Receivable and Contract Balances

 

We classify our right to consideration in exchange for deliverables as either a receivable or a contract asset (unbilled receivable). A receivable is a right to consideration that is unconditional (i.e. only the passage of time is required before payment is due). For example, we recognize a receivable for revenue related to our transaction or volume-based contracts when earned regardless of whether amounts have been billed. We present such receivables in trade accounts receivable, net in our consolidated statements of financial position at their net estimated realizable value. We maintain an allowance for doubtful accounts to provide for the estimated amount of receivables that may not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables, judgment, and other applicable factors.

 

A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented in current and other assets in our consolidated balance sheets and primarily relate to unbilled amounts on fixed-price contracts utilizing the output method of revenue recognition. The table below shows movements in contract assets:

 

   

Contract

assets

  

Balance – June 30, 2023

   $ 295,011  

Revenue recognized during the period but not billed

     -  

Amounts reclassified to accounts receivable

     (10,000

)

Other

     (29,439

)

Balance – March 31, 2024

   $ 255,572  (1)

 

 

(1)

Contract asset balances for March 31, 2024 include a current and a long-term contract asset of $147,520 and $108,052, respectively.

 

Our contract assets and liabilities are reported at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

The table below shows movements in the deferred revenue balances (current and noncurrent) for the period:

 

   

Contract

liability

  

Balance – June 30, 2023

   $ 1,903,001  

Amounts billed but not recognized as revenue

     1,767,483  

Revenue recognized related to the opening balance of deferred revenue

     (1,204,222

)

Balance – March 31, 2024

   $ 2,466,262  

 

Our contract assets and liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

- 9 -
 

 

Disaggregation of Revenue

 

The table below presents disaggregated revenue from contracts with customers by contract-type. We believe this disaggregation best depicts the nature, amount, timing and uncertainty of our revenue and cash flows that may be affected by industry, market, and other economic factors:

 

   

Three Months Ended

    

Nine months Ended

  
   

March 31,

    

March 31,

  
   

2024

    

2023

    

2024

    

2023

  
                                 

Recurring revenue – subscription and support services

   $ 5,078,866     $ 4,811,634     $ 15,250,302     $ 14,232,827  

Non-recurring revenue – setup and training services

     6,000       12,467       20,427       62,264  
    $ 5,084,866     $ 4,824,101     $ 15,270,729     $ 14,295,091  

 

Earnings Per Share

 

Basic net income per share of Common Stock (“Basic EPS”) excludes dilution and is computed by dividing net income applicable to Common Stockholders by the weighted average number of Common Stock outstanding during the period. Diluted net income per share of Common Stock (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue shares of Common Stock were exercised or converted into Common Stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an antidilutive effect on net income per share of Common Stock.

 

For the three and nine months ended March 31, 2024 and 2023, warrants to purchase 23,737 shares of our common stock at an exercise price of $10.00 per share were anti-dilutive and not included in the computation of diluted earnings per share because the exercise price of the options was greater than the average price of common stock for the quarter.

 

The following table presents the components of the computation of basic and diluted earnings per share for the periods indicated:

 

   

Three Months Ended

    

Nine months Ended

  
   

March 31,

    

March 31,

  
   

2024

    

2024

    

2023

    

2023

  

Numerator

                                

Net income applicable to common shareholders

   $ 1,416,082     $ 1,516,409     $ 3,952,557     $ 3,773,643  
                                 

Denominator

                                

Weighted average common shares outstanding, basic

     18,194,000       18,394,000       18,194,000       18,408,000  

Warrants to purchase Common Stock

     760,000       357,000       680,000       294,000  

Weighted average common shares outstanding, diluted

     18,954,000       18,751,000       18,874,000       18,702,000  
                                 

Net income per share

                                

Basic

   $ 0.08     $ 0.08     $ 0.22     $ 0.20  

Diluted

   $ 0.08     $ 0.08     $ 0.21     $ 0.20  

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform with the current year’s presentation. These reclassifications have no impact on the previously reported results.

 
- 10 -
 

 
 

NOTE 3.

EQUITY

 

Restricted Stock Units

  

Restricted

Stock Units

    

Weighted

Average
Grant Date
Fair Value

($/share)

  
                 

Outstanding at June 30, 2023

     907,451     $ 5.30  

Granted

     15,130       10.55  

Vested and issued

     (58,437

)

     5.66  

Forfeited

     -       -  

Outstanding at March 31, 2024

     864,144     $ 5.37  

 

As of March 31, 2024, there were zero restricted stock units outstanding that had vested but for which shares of Common Stock had not yet been issued pursuant to the terms of the applicable agreement.

 

As of March 31, 2024, there was approximately $4.6 million of unrecognized stock-based compensation obligations under our equity compensation plans. The stock-based compensation obligation is in connection with certain employment agreements which have a deferral option at the Board’s discretion. At the end of the deferral period, the stock-based compensation expense associated with the obligation is expected to be recognized on a straight-line basis over a period of three years.

 

Warrants

 

Outstanding warrants were issued in connection with private placements of the Company’s Common Stock and with the restructuring of the Series B Preferred that occurred in March of 2018. The following table summarizes information about fixed stock warrants outstanding at March 31, 2024:

 

Warrants Outstanding

at March 31, 2024

    

Warrants Exercisable

at March 31, 2024

  

Range of

exercise

prices

   

Number

Outstanding

    

Weighted

average

remaining
contractual

life (years)

    

Weighted

average

exercise price

    

Number

exercisable

    

Weighted

average

exercise price

  
$ 4.00       1,085,068       1.85     $ 4.00       1,085,068     $ 4.00  
$ 10.00       23,737       1.82     $ 10.00       23,737     $ 10.00  
          1,108,805       1.85     $ 4.13       1,108,805     $ 4.13  

 

During the quarter ended March 31, 2023, the Company’s Board of Directors approved the modification to extend the expiration dates of the Company’s existing January 26, 2023 and February 5, 2023 warrants by an additional three years. Accordingly, all the Company’s outstanding warrants have been extended and are anticipated to expire or be exercised on or before the quarter ending March 31, 2026.

 

Preferred Stock

 

The Company’s articles of incorporation currently authorize the issuance of up to 30,000,000 shares of ‘blank check’ preferred stock, par value $0.01 (“Preferred Stock”), with designations, rights, and preferences as may be determined from time to time by the Company’s Board of Directors, of which 700,000 shares are currently designated as Series B Preferred Stock (“Series B Preferred”) and 550,000 shares are designated as Series B-1 Preferred Stock (“Series B-1 Preferred”). Both classes of Series B Preferred Stock pay dividends at a rate of 7% per annum if paid by the Company in cash, or 9% if paid by the Company by the issuance of additional shares of Series B-1 Preferred, or Series B-1 Preferred, as applicable.

 

Preferred Redemption

 

Section 4 of the Company’s First Amended and Restated Certificate of Designation of the Relative Rights, Powers and Preferences of the Series B-1 Preferred Stock, as amended (the “Series B-1 COD”) provides the Company’s Board of Directors with the right to redeem any or all of the outstanding shares of the Company’s Series B-1 Preferred for a cash payment of $10.70 per share at any time upon providing the holders of Series B-1 Preferred at least ten days written notice that sets forth the date on which the redemption will occur (the “Redemption Notice”).

 

On August 29, 2023, the Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). The Preferred Redemption is to occur over the next three years from August 29, 2023.

 

- 11 -
 

 

As of March 31, 2024, a total of 625,375 shares of Series B Preferred and 72,216 shares of Series B-1 Preferred were issued and outstanding. Since inception, a total of 140,186 Preferred shares at the redemption price of $10.70 per share have been redeemed for a total of $1,499,990.

 

The following table provides information about the redemption and retirement of the Series B Preferred during the nine months ended March 31, 2024:

 

   

Series B Preferred

  

Period (1)

  

Total
Number of
Shares
Redeemed

    

Price Paid
Per Share

    

Dollars

Expended

by Period

under the

Preferred

Redemption

    

Remaining
Amount
Available
for Future
Preferred

Redemption

  

July 1, 2023 – September 30, 2023:

     -     $ 10.70     $ -     $    

October 1, 2023 – December 31, 2023:

     -     $ 10.70     $ -     $ 6,691,513  

January 1, 2024 – March 31, 2024:

     -     $ 10.70     $ -     $ 6,691,513  

Total

     -             $ -     $ 6,691,513  

 

The following table provides information about the redemption and retirement of the Series B-1 Preferred during the three months ended March 31, 2024:

 

   

Series B-1 Preferred

  

Period (1)

  

Total
Number of
Shares
Redeemed

    

Price Paid
Per Share

    

Dollars

Expended

by Period

under the

Preferred

Redemption

    

Remaining
Amount
Available
for Future
Preferred

Redemption

  

July 1, 2023 – September 30, 2023:

     -     $ 10.70     $ -     $    

October 1, 2023 – December 31, 2023:

     70,093     $ 10.70     $ 749,995     $ 1,522,706  

January 1, 2024 – March 31, 2024:

     70,093     $ 10.70     $ 749,995     $ 772,711  

Total

     140,186             $ 1,499,990     $ 772,711  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.

 

Share Repurchase Program

 

On May 9, 2019, our Board of Directors approved the repurchase of up to $4.0 million in shares of our Common Stock, which repurchases may be made in privately negotiated transactions or in the open market at prices per share not exceeding the then-current market prices (the “Share Repurchase Program”). Under the Share Repurchase Program, management has discretion to determine the dollar amount of shares to be repurchased and the timing of any repurchases in compliance with applicable laws and regulations, including Rule 10b-18 of the Exchange Act.

 

On March 17, 2020, the Board, given the extreme uncertainty due to COVID-19 at the time, suspended the Share Repurchase Program.

 

On May 18, 2021, our Board of Directors resumed its Share Repurchase Program, and increased the number of shares of Common Stock available to repurchase under the Share Repurchase Program by an additional $4 million bringing the total number of Common Stock authorized to repurchase under the Share Repurchase Program to $8.0 million.

 

On August 31, 2021, our Board of Directors approved a further increase to its Share Repurchase program to $12.0 million in shares of our Common Stock which added an additional $4 million to the Share Repurchase Program.

 

- 12 -
 

 

On May 10, 2022, our Board of Directors approved an increase of $9.0 million in the number of shares of Common Stock available to repurchase under the Share Repurchase Program.

 

Since inception of the Share Repurchase Program through March 31, 2024, a total of $21,000,000 in shares of Common Stock have been approved under the Share Repurchase Program, and 2,122,703 shares of Common Stock have been repurchased at an average purchase price of $6.13, resulting in $7,992,206 remaining available to repurchase under the current Share Repurchase Program. From time-to-time, our Board of Directors may authorize further increases to our Share Repurchase Program. In addition, the Share Repurchase Program may also be suspended for periods of time or discontinued at any time, at the Board’s discretion.

 

The following table provides information about repurchases of our Common Stock registered pursuant to Section 12 of the Exchange Act, during the three months ended March 31, 2024:

 

Period (1)

  

Total
Number of
Shares
Purchased

    

Average
Price Paid
Per Share

    

Dollars

Expended

by Period

Under the

Plans or
Programs

    

Remaining
Amount
Available
for Future
Share
Repurchases
Under the
Plans or
Programs

 

July 1, 2023 – September 30, 2023

     155,025     $ 8.53     $ 1,322,082     $ 8,185,698  

October 1, 2023 – December 31, 2023:

     22,012     $ 8.79     $ 193,492     $ 7,992,206  

January 1, 2024 – March 31, 2024:

     -     $ -     $ -     $ 7,992,206  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
 

NOTE 4.

RELATED PARTY TRANSACTIONS

 

During the nine months ended March 31, 2024, the Company continued to be a party to a service agreement (the “Service Agreement”) with Fields Management, Inc. (“FMI”), pursuant to which FMI provided certain executive management services to the Company, including designating Randall K. Fields to perform the functions of President and Chief Executive Officer for the Company. Mr. Fields, FMI’s designated executive, who also serves as the Company’s Chair of the Board of Directors, controls FMI. The Company had no payables to FMI under the Service Agreement as of March 31, 2024 or June 30, 2023. During the nine months ended March 31, 2024 and 2023, the Company paid FMI $727,352 and $693,045, respectively, in connection with the Service Agreement.

 

During the nine months ended March 31, 2024, the Company, the Company redeemed and retired $1,499,990 in Series B-1 Preferred from Mr. Randall K. Fields, affiliates of Mr. Fields, and Robert W. Allen. Mr. Allen is a director of the Company.

 

 

NOTE 5.

RECENT ACCOUNTING PRONOUNCEMENTS

 

The Company has reviewed newly issued accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on its consolidated condensed financial statements as a result of future adoption.

 

 

NOTE 6.

SUBSEQUENT EVENTS

 

In accordance with the Subsequent Events Topic of the FASB ASC 855, we have evaluated subsequent events through the filing date and determined that no subsequent events occurred that were reasonably expected to impact the consolidated condensed financial statements presented herein.

 

- 13 -
 

 
 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements. The words or phrases “would be”, “will allow”, “intends to”, “will likely result”, “are expected to”, “will continue”, “is anticipated”, “estimate”, “project”, or similar expressions are intended to identify “forward-looking statements”. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties, including those risks factors contained in our June 30, 2023 Annual Report on Form 10-K, incorporated by reference herein. Statements made herein are as of the date of the filing of this Report with the Securities and Exchange Commission (“SEC”) and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we do not undertake, and specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

 

Overview

 

ReposiTrak, Inc., a Nevada corporation (“ReposiTrak”, “We”, “us”, “our” or the “Company”) is a Software-as-a-Service (“SaaS”) which operates a business-to-business (“B2B”) e-commerce, compliance & traceability, and supply chain management platform that partners with retailers, wholesalers, distributors and their product suppliers to (a) help them manage specific programs, such as out-of-stock management and scan-based trading; (b) reduce risk in their supply chain by managing compliance documents and data; ensure compliance with new regulatory requirements supporting traceability; and (c) improve product ordering and forecasting in order to accelerate sales, control risks, and improve supply chain efficiencies.

 

The Company’s services are grouped in three application suites:

 

 

1.

ReposiTrak Compliance Management (“Compliance”) solutions, which helps the Company’s customers vet suppliers and reduce a company’s potential regulatory, legal, and criminal risk from its supply chain partners by providing a way for them to ensure these suppliers are compliant with food safety regulations, such as the Food Safety Modernization Act of 2011 (“FSMA”);
     
 

2.

ReposiTrak Traceability Network (“Traceability” or “RTN”), which helps the Company’s customers comply with federal regulatory requirements of traceability and provides the lowest cost, easiest to use way to manage the capture and sharing of key data elements (KDEs) now required by Section 204d of FSMA 2011 as designated products move through the supply chain at each ‘event’ known as a ‘critical tracking event’ or “CTE”, which includes tracking from farm to shelf; and
     
 

3.

ReposiTrak Supply Chain Solutions (“Supply Chain”), which help the Company’s customers to more efficiently manage various interactions with their suppliers. In other words, it provides customers with greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their supply chain faster and more cost effectively, and it helps them to manage these relationships more efficiently, enhancing revenue while lowering working capital, labor costs and reducing waste.

 

The Company’s services are delivered though proprietary software products designed, developed, marketed, and supported by the Company. These products provide visibility and facilitate improved business processes among all key constituents in the supply chain, starting with the retailer and moving backwards to suppliers and eventually to raw material providers.

 

The Company provides cloud-based applications and services that address e-commerce, supply chain, food safety, compliance, and traceability activities. The principal customers for the Company’s products are household name multi-store food retail chains and restaurants including their suppliers, branded food manufacturers, food wholesalers and distributors, and other food service businesses.

 

The Company has a hub and spoke business model. The Company is typically engaged by retailers and wholesalers (“Hubs”), which in turn require their suppliers (“Spokes”) to utilize the Company’s services.

 

- 14 -
 

 

On December 21, 2023, the Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc. The Company is incorporated in the State of Nevada and has two principal subsidiaries: PC Group, Inc., a Utah corporation (98.76% owned) (“PCG Utah”) and Park City Group, Inc., a Delaware corporation (100% owned) (“PCG Delaware” and together with PCG Utah, the “Subsidiaries”). All intercompany transactions and balances have been eliminated in the Company’s consolidated condensed financial statements, which contain the operating results of the operations. The Company has no business operations separate from the operations conducted through its Subsidiaries.

 

The Company’s principal executive offices are located at 5282 South Commerce Drive, Suite D292, Murray, Utah 84107. Its telephone number is (435) 645-2000. Its website address is www.repositrak.com. 

 

Recent Developments

 

Corporate Name Change

 

In connection with the rebranding of the Company, on December 21, 2023, the Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc., pursuant to a short-form merger with its wholly owned subsidiary, ReposiTrak, Inc., a Utah corporation, with the Company remaining as the surviving entity.

 

Transfer of listing from NASDAQ to NYSE

 

The Company filed a Registration Statement on Form 8-A in connection with the transfer of the listing of its common stock, par value $0.01 per share (“Common Stock”), from the Nasdaq Capital Market of The Nasdaq Stock Market LLC (“Nasdaq”) to the New York Stock Exchange (the “NYSE”). The Company commenced the trading of its Common Stock on the NYSE on November 2, 2023 under the symbol “TRAK.” Trading on the Nasdaq Capital Market ceased concurrently with the NYSE listing.

 

Dividend Payment

 

On March 18, 2024, the Company’s Board of Directors declared a quarterly cash dividend of $0.0165 per share ($0.066 per year), payable to shareholders of record on March 28, 2024, which were paid to shareholders of record on or about May 10, 2024. Based on the closing prices on March 31, 2024, this represented an annual dividend yield of approximately 0.42%. Subsequent quarterly dividends will be paid within 45 days of each record date of June 30, 2024, September 30, 2024 and December 31, 2024

 

Redemption and Retirement of Preferred Stock

 

On August 29, 2023, the Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”).  The Preferred Redemption is to occur over the next three years from August 29, 2023.

 

As of March 31, 2024, a total of zero shares of Series B Preferred and 140,186 shares of Series B-1 Preferred were redeemed and retired, for aggregate consideration of $0 and $1,499,990 in the case of Series B Preferred and Series B-1 Preferred, respectively, resulting in a total of 625,375 shares of Series B Preferred and 72,216 shares of Series B-1 Preferred issued and outstanding at March 31, 2024.

 

Global Pandemics, Bank Failures, and Geopolitical Conflicts

 

The impact of global pandemics, including COVID 19, banking failures, geopolitical conflicts, including the war in Ukraine and tensions in the Middle East, creates much uncertainty in the global marketplace. Management continues to monitor the ongoing impact of these events on all aspects of its business, including how they impact its services, customers, employees, vendors, and business partners now and in the future. While these events did not materially adversely affect the Company’s financial results and business operations during the year ended June 30, 2023 or during the nine months ended March 31, 2024, we are unable to predict the impact that these events, including geopolitical conflicts, will have on its future financial position and operating results due to numerous uncertainties.

 

Federal Regulation & Traceability: FSMA 204(d) and USDA SOE

 

In 2020, the United States Food & Drug Administration (“FDA”) announced the “New Era of Smarter Food Safety” blueprint. It “outlines achievable goals to enhance traceability, improve predictive analytics, respond more rapidly to outbreaks, address new business models, reduce contamination of food, and foster the development of stronger food safety cultures.”

 

In November 2022, the FDA announced the final rule on the Food Safety Modernization Act Section 204(d) (“FSMA 204”) - Traceability for High-Risk Foods.

 

On January 20, 2023, the rule became effective and applies to any person or Company that manufactures, processes, packs or hold foods the FDA considers to be high risk for food borne illness, the so-called Food Traceability List (“FTL”). The FTL is comprised of 16 product categories of food, which represent thousands of products commonly sold in grocery and convenience stores, and all restaurants. As a result, every grocery distributor, wholesaler and retailer, and the food service supply chain, must now institute a traceability program that enables the capture, creation and sharing of specific Key Data Elements (“KDEs”) prescribed by the FDA and required for traceability, at each designated Critical Tracking Event (“CTE”) in the supply chain, for thousands of items.

 

- 15 -
 

 

FSMA 204 requires the traceability data records to be stored for two years, and be retrievable such that specific data records can be presented within 24 hours of a request from the FDA. FSMA 204 is ultimately about supply chain data recording record keeping, resulting is an enormous amount of data to manage, across more than one million supply chain and retail facilities.

 

The deadline for compliance with FSMA 204 is January 20, 2026, and nearly every company impacted will require some type of technical systems support to meet the requirement. 

 

While the FTL includes thousands of product types, the FDA has made it clear in its communications that the list is only the beginning. The FDA states that it would “encourage the voluntary adoption of these practices industry-wide,” There are some strong early indications that the industry will move to complete traceability of all food products within the next few years.

 

In January of 2023, the United States Department of Agriculture (the “USDA”), which governs the National Organic Program, instituted new requirements under the Strengthening Organic Enforcement (“SOE”) rule. This rule will be enforced beginning in March 2024. The SOE is designed to reduce the amount of fraud in the organic products industry by increasing the requirements for facility certification and traceability of organic products. The timing and scope of the SOE traceability requirement will accelerate the adoption of traceability solutions across the entire food supply chain, much sooner than many anticipated.

 

In December 2023, one of the largest grocery retail chains in the US sent their suppliers a communication detailing their new traceability program requirements for ALL food products, not just the FDA required foods, with a deadline for compliance of June 2025, significantly earlier than the FDA FSMA 204 compliance deadline. It’s estimated that this new requirement could impact up to 20,000 food companies. If history is any indicator, we expect other large chains will follow the precedent set by this industry leader, resulting in effectively every supplier of food products sold in the United States will have the ability to simply and cost effectively share traceability data with their customers. 

 

Traceability is, by definition, a supply chain data management issue, which is ReposiTrak’s core expertise. That’s why we’ve made it our goal to develop a traceability solution that’s easy, inexpensive and exceeds FDA’s requirements. The ReposiTrak Traceability Network (“RTN”) is now the largest and fastest growing traceability solution, connecting thousands of supplier locations to thousands of food wholesaler and retail locations, using low cost, easy to deploy technology, on the ReposiTrak platform. As the largest connected network of food suppliers, wholesalers and retailers in the world, the ReposiTrak Traceability Network is well positioned to provide end-to-end traceability to provide a safer food supply chain, tighten controls on food waste, and implement a food recall response that saves lives and money.

 

Results of Operations

 

Comparison of the Three Months Ended March 31, 2024 to the Three Months Ended March 31, 2023.

 

Revenue

 

   

Fiscal Quarter Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Revenue

   $ 5,084,866     $ 4,824,101     $ 260,765       5 %

 

Revenue was $5,084,866 and $4,824,101 for the three months ended March 31, 2024 and 2023, respectively, a 5% increase year-over-year. The increase in revenue was due to growth in recurring subscription revenue, in all lines of business which includes compliance, supply chain and traceability. This is the result of growing industry and consumer response to food contaminations and food safety hazards, whether biological, chemical, physical, or allergenic. The risks have elevated regulatory requirements, documentation requisites, and principally “where does your food come from” transparency on grocery retailers and their suppliers.  As more and more retailers, wholesalers and distributors adopt the increased regulatory disclosure requirements, the Company has seen a corresponding rise in demand for its services.

 

- 16 -
 

 

Although no assurances can be given, we continue to focus our sales efforts on marketing our software services on a recurring subscription basis and placing less emphasis on transactional revenue. However, we believe there will continue to be a small percentage of customers that will, from time to time, require buying a particular service outright (i.e., a license). Nonetheless, we will continue to deemphasize non-recurring transactional revenue when we are able.

 

Cost of Services and Product Support

 

   

Fiscal Quarter Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Cost of services and product support

   $ 831,912     $ 840,272     $ (8,360 )     -1 %

Percent of total revenue

     16 %     17 %                

 

Cost of services and product support was $831,912 and $840,272 for the three months ended March 31, 2024 and 2023, respectively, a 1% decrease. This $8,360 decrease is primarily the result of the decrease of certain hardware and software support and maintenance costs.

 

Sales and Marketing Expense

 

   

Fiscal Quarter Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Sales and marketing

   $ 1,349,838     $ 1,239,946     $ 109,892       9 %

Percent of total revenue

     27 %     26 %                

 

Sales and marketing expense was $1,349,838 and $1,239,946 for the three months ended March 31, 2024 and 2023, respectively, a 9% increase. The increase in sales and marketing expense was primarily the result of an increase in trade show expense, investment in FSMA 204 traceability marketing, and higher sales travel expense. As the pandemic continues to abate, customers and prospects are returning to in person meetings. The largest contributor to the increase in sales and marketing expense has been an increase in travel cost and trade shows. We believe this trend will continue as many of our trading partners and industry associations will continue to require our assistance in addressing their compliance and supply chain needs particularly in the case of the 2026 traceability deadline.

 

General and Administrative Expense

 

   

Fiscal Quarter Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

General and administrative

   $ 1,352,197     $ 916,237     $ 435,960       48 %

Percent of total revenue

     27 %     19 %                

 

General and administrative expense was $1,352,197 and $916,237 for the three months ended March 31, 2024 and 2023, respectively, a 48% increase. The increase in general and administrative expense was primarily due to refund of payroll taxes associated with the ERC that occurred in the prior fiscal year. The ERC was a refund of certain payroll taxes for businesses that continued to pay employees while shut down due to the COVID-19 pandemic or had significant declines in gross receipts. During the prior fiscal year, the Company received approximately $1.175 million in payroll tax refunds, net of fees. The ERC credit was partially offset by increases in bad debt expense and increases in cost of benefits for employees.

 

- 17 -
 

 

Depreciation and Amortization Expense

 

   

Fiscal Quarter Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Depreciation and amortization

   $ 288,576     $ 305,864     $ (17,288 )     -6 %

Percent of total revenue

     6 %     6 %                

 

Depreciation and amortization expense was $288,576 and $305,864 for the three months ended March 31, 2024 and 2023, respectively, a decrease of 6%. The decrease was due to certain assets becoming fully depreciated over their useful lives.

 

Other Income and Expense

 

   

Fiscal Quarter Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Net other income (expense)

   $ 348,084     $ 301,238     $ 46,846       16 %

Percent of total revenue

     7 %     6 %                

 

Net other income was $348,084 for the three months ended March 31, 2024, compared to net other income of $301,238 for the three months ended March 31, 2023. Other income increased due to an increase in interest income attributable to higher interest rates on fixed income instruments on our excess cash.

 

Preferred Dividends

 

   

Fiscal Quarter Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Preferred dividends

   $ 134,345     $ 146,611     $ (12,266 )     -8 %

Percent of total revenue

     3 %     3 %                

 

Preferred dividends accrued on the Company’s Preferred Stock was $134,345 for the three months ended March 31, 2024 and $146,611 for the three months ended March 31, 2023. Dividends decreased due to the redemption of Preferred Stock during the period. Although no assurances can be given, the Company anticipates redeeming the remaining outstanding Preferred Stock over the next 2.5 years.

 

Comparison of the Nine months Ended March 31, 2024 to the Nine months Ended March 31, 2023.

 

Revenue

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Revenue

   $ 15,270,729     $ 14,295,091     $ 975,638       7 %

 

Revenue was $15,270,729 and $14,295,091 for the nine months ended March 31, 2024 and 2023, respectively, a 7% increase year-over-year. The increase in revenue was due to growth in recurring subscription revenue, in all lines of business which includes compliance, supply chain and traceability. This is the result of growing industry and consumer response to food contaminations and food safety hazards, whether biological, chemical, physical, or allergenic. The risks have elevated regulatory requirements, documentation requisites, and principally “where does your food come from” transparency on grocery retailers and their suppliers. As more and more retailers, wholesalers and distributors adopt the increased regulatory disclosure requirements, the Company has seen a corresponding rise in demand for its services.

 

Although no assurances can be given, we continue to focus our sales efforts on marketing our software services on a recurring subscription basis and placing less emphasis on transactional revenue. However, we believe there will continue to be a small percentage of customers that will, from time to time, require buying a particular service outright (i.e., a license). Nonetheless, we will continue to deemphasize non-recurring transactional revenue when we are able.

 

- 18 -
 

 

Cost of Services and Product Support

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Cost of services and product support

   $ 2,571,533     $ 2,539,618     $ 31,915       1 %

Percent of total revenue

     17 %     18 %                

 

Cost of services and product support was $2,571,533 and $2,539,618 for the nine months ended March 31, 2024 and 2023, respectively, a 1% increase. This $31,915 increase is primarily the result of increased offshore developer headcount and support services in effort to support the acceleration and expansion of the FSMA 204 initiative. Given the demand in traceability the Company has also expended additional resources on further upgrading its security and confidentiality to increase protection of customer data. 

 

Sales and Marketing Expense

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Sales and marketing

   $ 4,119,716     $ 3,667,017     $ 452,699       12 %

Percent of total revenue

     27 %     26 %                

 

Sales and marketing expense was $4,119,716 and $3,667,017 for the nine months ended March 31, 2024 and 2023, respectively, a 12% increase. The increase in sales and marketing expense was primarily the result of an increase in commission, trade show expense, investment in FSMA 204 traceability marketing, and higher sales travel expense. As the pandemic continues to abate, customers and prospects are returning to in person meetings. The largest contributors to the increase in sales and marketing expense has been an increase in commission and FSMA 204 traceability marketing. We believe the uptick in marketing costs will flatten over the next twelve months as awareness of the 2026 traceability regulatory deadline approaches.

 

General and Administrative Expense

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

General and administrative

   $ 3,978,798     $ 3,392,056     $ 586,742       17 %

Percent of total revenue

     26 %     24 %                

 

General and administrative expense was $3,978,798 and $3,392,056 for the nine months ended March 31, 2024 and 2023, respectively, a 17% increase. The increase in general and administrative expense was primarily due to refund of payroll taxes associated with the Employee Retention Credit (“ERC”) that occurred in the prior fiscal year. The ERC was a refund of certain payroll taxes for businesses that continued to pay employees while shut down due to the COVID-19 pandemic or had significant declines in gross receipts. During the prior fiscal year, the Company received approximately $1.175 million in payroll tax refunds, net of fees. The ERC credit was partially offset by increases in bad debt expense and increases in cost of benefits for employees.

 

Depreciation and Amortization Expense

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Depreciation and amortization

   $ 897,479     $ 771,030     $ 126,449       16 %

Percent of total revenue

     6 %     5 %                

 

Depreciation and amortization expense was $897,479 and $771,030 for the nine months ended March 31, 2024 and 2023, respectively, an increase of 16%. The increase was due to additional assets acquired in the prior fiscal year. Given the rising global hacks on software companies, banks, and financial institutions, we spent approximately $420,000 on security, backup, storage, and redundancy. The upgrades were financed through a leasing agent with an effective APR rate of 4.45%.

 

- 19 -
 

 

Other Income and Expense

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Net other income (expense)

   $ 951,412     $ 568,112     $ 383,300       68 %

Percent of total revenue

     6 %     4 %                

 

Net other income was $951,412 for the nine months ended March 31, 2024, compared to net other income of $568,112 for the nine months ended March 31, 2023. Other income increased due to an increase in interest income attributable to higher interest rates on fixed income instruments on excess cash. When the Federal Reserve begins to cut rates in the future, it is unlikely the Company will be able to maintain the same interest income on its existing cash balances without taking additional credit risk.

 

Preferred Dividends

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Preferred dividends

   $ 427,567     $ 439,833     $ (12,266 )     -3 %

Percent of total revenue

     3 %     3 %                

 

Dividends accrued on the Company’s Series B-1 Preferred was $427,567 and $439,833 for the nine months ended March 31, 2024 and 2023, respectively. Dividends decreased due to the redemption of Preferred Stock.

 

Financial Position, Liquidity and Capital Resources

 

We believe that our existing cash and short-term investments, together with funds generated from operations, are sufficient to fund operating and investment requirements for at least the next twelve months. Our future capital requirements will depend on many factors, including macroeconomic conditions, our rate of revenue growth, sales and marketing activities, the timing and extent of spending required for research and development efforts and the continuing market acceptance of our products and services.

 

   

As of

    

Variance

  
   

March 31,

2024

    

June 30,

2023

    

Dollars

    

Percent

  

Cash and cash equivalents

   $ 24,452,680     $ 23,990,879     $ 461,801       2 %

 

We have historically funded our operations with cash from operations, equity financings, and borrowings from our existing line of credit with U.S. Bank N.A. (the “Bank”), which was revised on October 6, 2021, and again in 2022. In March 2024, given our strong financial position, we terminated the credit facility with our bank.

 

Cash was $24,452,680 and $23,990,879 at March 31, 2024 and June 30, 2023, respectively. This 2% increase is primarily the result of higher revenue and the corresponding cash receipts from customers.

 

Net Cash Flows from Operating Activities

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Cash provided by operating activities

   $ 4,910,741     $ 7,065,890     $ (2,155,149 )     -31 %

 

Net cash provided by operating activities is summarized as follows:

 

   

Nine months Ended

March 31,

  
   

2024

    

2023

  

Net income

   $ 4,380,124     $ 4,213,476  

Noncash expense and income, net

     1,428,402       2,329,265  

Net changes in operating assets and liabilities

     (897,785 )     523,149  
    $ 4,910,741     $ 7,065,890  

 

- 20 -
 

 

Net cash provided by operating activities for the nine months ended March 31, 2024 was $4,910,741 as compared to net cash provided by operating activities of $7,065,890 for the nine months ended March 31, 2023. Net cash provided by operating activities decreased 31% due principally to an increase in accounts receivable and a decrease in accounts payable. Noncash expense decreased by $900,863 in the nine months ended March 31, 2024, compared to nine months ended March 31, 2023 as a result of a decrease in bad debt expense and stock compensation expense offset by an increase in depreciation and amortization.

 

Net Cash Flows from Investing Activities

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Cash used in investing activities

   $ (48,538 )   $ (903,187 )   $ (854,649 )     -95 %

 

Net cash used in investing activities for the nine months ended March 31, 2024 was $48,538 compared to net cash used in investing activities of $903,187 for the nine months ended March 31, 2023. This decrease in cash used in investing activities for the nine months ended March 31, 2024 was due to capitalization of certain software costs and purchases of property and equipment in the prior fiscal year that did not occur in the nine months ended March 31, 2024.

 

Net Cash Flows from Financing Activities

 

   

Nine months Ended

March 31,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Cash used in financing activities

   $ (4,400,402 )   $ (4,682,158 )   $ (281,756 )     -6 %

 

Net cash used in financing activities totaled $4,400,402 for the nine months ended March 31, 2024, as compared to cash used in financing activities of $4,682,158 for the nine months ended March 31, 2023. The decrease in cash used in financing activities is due to the payoff of our line of credit arrangement with the Bank in the prior fiscal year offset by net cash used in financing activities for the payment of Common Stock dividends, the purchase of Common Stock under the Share Repurchase Program, and the redemption and retirement of shares of Preferred Stock.

 

Liquidity and Working Capital

 

At March 31, 2024, the Company had positive working capital of $24,182,808, as compared with positive working capital of $23,042,199 at June 30, 2023. This $1,140,609 increase in working capital is primarily due to an increase in accounts receivable and decrease in prepaid and other assets offset by a decrease in contract liabilities and an increase in deferred revenue. Cash and cash equivalents also increased due to cash receipts from customers who have signed up for, among other offerings, the ReposiTrak Traceability Network.

 

   

As of

March 31,

    

As of

June 30,

    

Variance

  
   

2024

    

2023

    

Dollars

    

Percent

  

Current assets

   $ 28,827,713     $ 27,274,620     $ 1,553,093       6 %

 

Current assets totaled $28,827,713 as of March 31, 2024, as compared to $27,274,620 as of June 30, 2023. The increase in current assets is primarily attributable to the increase in cash and accounts receivables offset by a decrease of prepaid expense and other current assets.

 

   

As of

March 31,

    

As of

June 30,

    

Variance

  
   

2024

    

2023

    

Change

    

Percent

 

Current liabilities

   $ 4,644,905     $ 4,232,421     $ 412,484       10 %

Current ratio

     6.21 %     6.44 %     0.23       - %

 

- 21 -
 

 

Current liabilities totaled $4,644,905 as of March 31, 2024 as compared to $4,232,421 as of June 30, 2023. The increase in current liabilities is primarily attributable to the increase in deferred revenue offset by a decrease in accrued liabilities and financing lease liabilities. As of March 31, 2024, the Company had zero bank debt.

 

On October 6, 2021, the Company and U.S. Bank N.A. (the “Bank”) executed a Revolving Credit Agreement (the "Revolving Credit Agreement”) and accompanying addendum (the "Addendum"), and Stand-Alone Revolving Note (the "Note" and collectively with the Revolving Credit Agreement and Addendum, the "Credit Agreement"), with an effective date of September 30, 2021. The Credit Agreement replaced the Company’s prior $6.0 million Revolving Credit Agreement and Stand-Alone Revolving Note between the Company and the Bank, as amended and revised on January 9, 2019, and provided the Company with a $10.0 million revolving line of credit that matured on March 31, 2023. The Credit Agreement contained customary affirmative and negative covenants and conditions to borrowing, as well as customary events of default. Among other things, the Company must maintain liquid assets equal to $12 million and maintain a Senior Funded Debt (as defined in the Credit Agreement) to EBITDA Ratio (as defined in the Credit Agreement) of not more than 3:1.

 

On April 28, 2023, the Company and the Bank executed an amendment to the Credit Agreement (the “Amendment”), with an effective date of March 31, 2023. The Amendment to the Credit Agreement sets forth that (1) the Company will increase its liquidity requirement from $10 million to $12 million, which the Company currently maintains over $22 million in cash and a current ratio of over 6:1, and (2) draws on the facility accrue interest at the annual rate, equal to 1.75% plus the one-month SOFR rate, instead of the previous LIBOR rate. As of March 31, 2024, the balance of the facility was zero. The Company had zero bank debt at March 31, 2024.

 

On March 15, 2024, given its strong financial position, the Company chose not to renew the Revolving Credit Agreement.  There were no amounts due at the time of renewal.

 

While no assurances can be given, management currently believes that the Company will continue to increase its cash flow from operations and working capital position in subsequent periods. The Company’s increase in anticipated cash flow from operations and working capital position is expected to be offset by the use of cash required to fund the Company’s quarterly cash dividends of $0.015 per share, announced on September 28, 2022, December 30, 2022, February 10, 2023, March 21, 2023, June 20, 2023, September 19, 2023, and of $0.0165 per share, announced on December 12, 2023 and March 18, 2024, as well as the  redemption and retirement of the Company’s Series B Convertible Preferred Stock and Series B-1 Preferred Stock (together, the “Preferred Stock”) for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). 

 

The Preferred Redemption is to occur over the next three years from August 29, 2023.  As of March 31, 2024, a total of zero shares of Series B Preferred and 140,186 shares of Series B-1 Preferred were redeemed and retired, for aggregate consideration of $0 and $1,499,990 in the case of Series B Preferred and Series B-1 Preferred, respectively. The Company believes it will have adequate cash resources to fund its operations, satisfy its debt obligations, and fund its anticipated quarterly cash dividends and Preferred Redemption for at least the next 12 months.

 

Off-Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenue, and results of operation, liquidity or capital expenditures.

 

Contractual Obligations

 

Total contractual obligations and commercial commitments as of March 31, 2024 are summarized in the following table:

 

   

Operating

Leases

    

Financing

Leases

  

Less than 1 Year

   $ 74,929     $ 220,268  

1-3 Years

     156,670       -  

3-5 Years

     74,867       -  

Total lease payments

     306,466       220,268  

Less imputed interest

     (28,065 )     (4,994 )

Total

   $ 278,401     $ 215,274  

 

- 22 -
 

 

Critical Accounting Policies

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operations discusses the Company’s financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles.

 

We commenced operations in the software development and professional services business during 1990. The preparation of our financial statements requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expense during the reporting period. On an ongoing basis, management evaluates its estimates and assumptions. Management bases its estimates and judgments on historical experience of operations and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Management believes the following critical accounting policies, among others, will affect its more significant judgments and estimates used in the preparation of our consolidated financial statements.

 

Income Taxes

 

In determining the carrying value of the Company’s net deferred income tax assets, the Company must assess the likelihood of sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions, to realize the benefit of these assets. If these estimates and assumptions change in the future, the Company may record a reduction in the valuation allowance, resulting in an income tax benefit in the Company’s statements of operations. Management evaluates whether to realize the deferred income tax assets and assesses the valuation allowance quarterly.

 

Goodwill and Other Long-Lived Asset Valuations

 

Goodwill and other long-lived assets assigned to specific reporting units are reviewed for possible impairment at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value. Management reviews the long-lived tangible and intangible assets for impairment when events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Management evaluates, at each balance sheet date, whether events and circumstances have occurred which indicate possible impairment. The carrying value of a long-lived asset is considered impaired when the anticipated cumulative undiscounted cash flows of the related asset or group of assets is less than the carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the estimated fair market value of the long-lived asset. Economic useful lives of long-lived assets are assessed and adjusted as circumstances dictate.

 

Revenue Recognition 

 

Effective July 1, 2018, the Company adopted the Financial Accounting Standards Board’s Accounting Standards Update 2014-09: Revenue from Contracts with Customers (Topic 606), and its related amendments (“ASU 2014-09”). ASU 2014-09 provides a unified model to determine when and how revenue is recognized and enhances certain disclosure around the nature, timing, amount and uncertainty of revenue and cash flows arising from customers.

 

ASU 2014-09 represents a change in the accounting model utilized for the recognition of revenue and certain expense arising from contracts with customers. The Company adopted ASU 2014-09 using a “modified retrospective” approach and, accordingly, revenue and expense totals for all periods before July 1, 2018 reflect those previously reported under the prior accounting model and have not been restated.

 

See Note 2 to our Unaudited Consolidated Financial Statements included in Part I, Item 1 of this Report for a full description of the impact of the adoption of new accounting standards on our financial statements. Following the adoption of this guidance, the revenue recognition for our sales arrangements remained materially consistent with our historical practice and there have been no material changes to our critical accounting policies and estimates as compared to our critical accounting policies and estimates included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023.

 

Share-Based Compensation

 

The Company accounts for its share-based compensation to employees and non-employees in accordance with FASB ASC 718, Compensation – Stock Compensation. Stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service or vesting period.

 

- 23 -
 

 

Leases

 

Effective July 1, 2019, the Company adopted the requirements of Accounting Standards Update No. 2016-02, "Leases (Topic 842)" ("ASU 2016-02"). All amounts and disclosures set forth in this Report have been updated to comply with this new standard with results for reporting periods beginning after July 1, 2019 presented under ASU 2016-02, while prior period amounts and disclosures are not adjusted and continue to be reported under the accounting standards in effect for the prior period.

 

Available-for-Sale Debt Investments

 

We classify our investments in fixed income securities as available-for-sale debt investments. Our available-for-sale debt investments primarily consist of U.S. government, U.S. government agency, non-U.S. government and agency, corporate debt, U.S. agency mortgage-backed securities, commercial paper and certificates of deposit. These available-for-sale debt investments are primarily held in the custody of a major financial institution. A specific identification method is used to determine the cost basis of available-for-sale debt investments sold. These investments are recorded in the Consolidated Balance Sheets at fair value. Unrealized gains and losses on these investments are included as a separate component of accumulated other comprehensive income (“AOCI”). We classify our investments as current based on the nature of the investments and their availability for use in current operations.

 

Impairment Consideration of Investments  

 

For our available-for-sale debt securities in an unrealized loss position, we determine whether a temporary or permanent credit loss exists. In this assessment, which requires judgment, among other factors, we consider the extent to which the fair value is less than the amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If factors indicate a permanent credit loss exists, an allowance for credit loss is recorded to other income (loss), net, limited by the amount that the fair value is less than the amortized cost basis. The amount of fair value change relating to all other factors will be recognized in other comprehensive income (“OCI”).

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Our business is conducted principally in the United States. As a result, our financial results are not affected by factors such as changes in foreign currency exchange rates or economic conditions in foreign markets. We do not engage in hedging transactions to reduce our exposure to changes in currency exchange rates, although if the geographical scope of our business broadens, we may do so in the future.

 

Our exposure to risk for changes in interest rates relates primarily to our investments in short-term financial instruments. Investments in both fixed rate and floating rate interest earning instruments carry some interest rate risk. The fair value of fixed rate securities may fall due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Partly as a result of this, our future interest income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that have fallen in estimated fair value due to changes in interest rates. However, as substantially all of our cash consist of bank deposits and short-term money market instruments, we do not expect any material change with respect to our net income as a result of an interest rate change. 

 

Our exposure to interest rate changes related to borrowing has been limited, and we believe the effect, if any, of near-term changes in interest rates on our financial position, results of operations and cash flows should not be material. At March 31, 2024, our debt portfolio was composed of only Leases – Effective APR Fixed is 4.55%. Total lease obligations are on a three-year straight-line basis.  The total cost is less than $400,000.

 

The table that follows presents fair values of principal amounts and weighted average interest rates for our investment portfolio as of March 31, 2024:

 

Cash:

  

Aggregate

Fair Value

    

Weighted

Average

Interest Rate

  

Cash

   $ 24,452,680       5.32 %

 

- 24 -
 

 

ITEM 4.

CONTROLS AND PROCEDURES

 

(a)

Evaluation of disclosure controls and procedures. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, an evaluation of the effectiveness of the design and operations of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of March 31, 2024 was completed. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer believe that our disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, including to ensure that information required to be disclosed by the Company is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

(b)

Changes in internal controls over financial reporting. The Company’s Chief Executive Officer and Chief Financial Officer have determined that there have been no changes in the Company’s internal control over financial reporting during the period covered by this report identified in connection with the evaluation described in the above paragraph that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

- 25 -
 

 

PART II

 

OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS

 

We are, from time-to-time, involved in various legal proceedings incidental to the conduct of our business. Historically, the outcome of all such legal proceedings has not, in the aggregate, had a material adverse effect on our business, financial condition, results of operations or liquidity. There is currently no pending or threatened material legal proceeding that, in the opinion of management, could have a material adverse effect on our business or financial condition.

 

ITEM 1A.

RISK FACTORS

 

There are no risk factors identified by the Company in addition to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

None.

 

 

ITEM 5.

OTHER INFORMATION

 

None.
 

 

ITEM 6.

EXHIBITS

 

31.1

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

104

Cover Page Interactive Data File - formatted in Inline XBRL (included as Exhibit 101)

 

- 26 -
 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

REPOSITRAK, INC. 
       

Date:  May 15, 2024

By:  

/s/ Randall K. Fields

  
   

Randall K. Fields 

  
   

Chair of the Board and Chief Executive Officer

(Principal Executive Officer)

  

 

 

REPOSITRAK, INC. 
       

Date: May 15, 2024

By:  

/s/ John R. Merrill

  
   

John R. Merrill

  
   

Chief Financial Officer

(Principal Financial Officer & Principal Accounting Officer)

  

 

 

- 27 -

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13A-14(A)

 

I, Randall K. Fields, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Q of ReposiTrak, Inc.;

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2024

By:

/s/ Randall K. Fields
   

Randall K. Fields

Chief Executive Officer and Chair of the Board

(Principal Executive Officer)

 

 

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13A-14(A)

 

I, John R. Merrill, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Q of ReposiTrak, Inc.;

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: May 15, 2024

By:

/s/ John R. Merrill
   

John R. Merrill

Chief Financial Officer

(Principal Financial Officer & Principal Accounting Officer)

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. Sec.1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the accompanying Quarterly Report of ReposiTrak, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), the undersigned, Randall K. Fields, Principal Executive Officer of the Company, certifies, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

Date: May 15, 2024

By:

/s/ Randall K. Fields
   

Randall K. Fields

Chief Executive Officer and Chair of the Board

(Principal Executive Officer)

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. Sec.1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the accompanying Quarterly Report of ReposiTrak, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), the undersigned, John R. Merrill, Principal Financial Officer of the Company, certifies, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

Date: May 15, 2024

By:

/s/ John R. Merrill
   

John R. Merrill

Chief Financial Officer

(Principal Financial Officer & Principal Accounting Officer)

 

 
v3.24.1.1.u2
Document And Entity Information - shares
 9 Months Ended
Mar. 31, 2024
May 15, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-34941  
Entity Registrant Name REPOSITRAK, INC.  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 37-1454128  
Entity Address, Address Line One 5282 South Commerce Drive, Suite D292  
Entity Address, City or Town Murray  
Entity Address, State or Province UT  
Entity Address, Postal Zip Code 84107  
City Area Code 435  
Local Phone Number 645-2000  
Title of 12(b) Security Common stock, par value $0.01 per share  
Trading Symbol TRAK  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   18,223,893
Entity Central Index Key 0000050471  
Current Fiscal Year End Date --06-30  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Amendment Flag false  
v3.24.1.1.u2
Consolidated Condensed Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2024
Jun. 30, 2023
Current Assets    
Cash and cash equivalents $ 24,452,680 $ 23,990,879
Receivables, net of allowance for doubtful accounts of $226,198 and $170,103 at March 31, 2024 and June 30, 2023, respectively 3,776,472 2,523,019
Contract asset – unbilled current portion 147,520 186,959
Prepaid expense and other current assets 451,041 573,763
Total Current Assets 28,827,713 27,274,620
Property and equipment, net 591,724 986,300
Other Assets:    
Deposits and other assets 22,414 22,414
Prepaid expense – less current portion 6,677 36,282
Contract asset – unbilled long-term portion 108,052 108,052
Operating lease – right-of-use asset 265,726 310,796
Goodwill 20,883,886 20,883,886
Capitalized software costs, net 463,036 698,281
Total Other Assets 21,914,041 22,322,511
Total Assets 51,333,478 50,583,431
Current liabilities    
Accounts payable 510,412 431,387
Accrued liabilities 1,390,232 1,620,000
Contract liability – deferred revenue 2,466,262 1,903,001
Operating lease liability – current 62,725 58,771
Notes payable and financing leases – current 215,274 219,262
Total current liabilities 4,644,905 4,232,421
Long-term liabilities    
Operating lease liability – less current portion 215,676 263,047
Notes payable and financing leases – less current portion 0 206,032
Total liabilities 4,860,581 4,701,500
Commitments and Contingencies  
Stockholders’ equity:    
Common Stock, $0.01 par value, 50,000,000 shares authorized; 18,221,527 and 18,309,051 issued and outstanding at March 31, 2024 and June 30, 2023, respectively 182,218 183,093
Additional paid-in capital 65,277,419 67,732,887
Accumulated other comprehensive loss (31,006) 0
Accumulated deficit (18,962,710) (22,042,427)
Total stockholders’ equity 46,472,897 45,881,931
Total liabilities and stockholders’ equity 51,333,478 50,583,431
Series B Preferred Stock [Member]    
Stockholders’ equity:    
Series B Preferred, 700,000 shares authorized; 625,375 shares issued and outstanding at March 31, 2024 and June 30, 2023; 6,254 6,254
Series B-1 Preferred Stock [Member]    
Stockholders’ equity:    
Series B Preferred, 700,000 shares authorized; 625,375 shares issued and outstanding at March 31, 2024 and June 30, 2023; 722 2,124
Customer Relationships [Member]    
Other Assets:    
Customer relationships $ 164,250 $ 262,800
v3.24.1.1.u2
Consolidated Condensed Balance Sheets (Unaudited) (Parentheticals) - USD ($)
Mar. 31, 2024
Jun. 30, 2023
Accounts Receivable, Allowance for Credit Loss, Current $ 226,198 $ 170,103
Preferred Stock, Par or Stated Value Per Share (in dollars per share) $ 0.01 $ 0.01
Preferred Stock, Shares Authorized (in shares)   30,000,000
Preferred Stock, Shares Authorized (in shares)   30,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) $ 0.01 $ 0.01
Common Stock, Shares Authorized (in shares) 50,000,000 50,000,000
Common Stock, Shares, Issued (in shares) 18,221,527 18,309,051
Common Stock, Shares, Outstanding, Ending Balance (in shares) 18,221,527 18,309,051
Series B Preferred Stock [Member]    
Preferred Stock, Shares Authorized (in shares) 700,000 700,000
Preferred Stock, Shares Authorized (in shares) 700,000 700,000
Preferred Stock, Shares Outstanding (in shares) 625,375 625,375
Preferred Stock, Shares Issued (in shares) 625,375 625,375
Series B-1 Preferred Stock [Member]    
Preferred Stock, Shares Authorized (in shares) 550,000 550,000
Preferred Stock, Shares Authorized (in shares) 550,000 550,000
Preferred Stock, Shares Outstanding (in shares) 72,216 212,402
Preferred Stock, Shares Issued (in shares) 72,216 212,402
v3.24.1.1.u2
Consolidated Condensed Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Revenue $ 5,084,866 $ 4,824,101 $ 15,270,729 $ 14,295,091
Operating expense:        
Cost of revenue and product support 831,912 840,272 2,571,533 2,539,618
Sales and marketing 1,349,838 1,239,946 4,119,716 3,667,017
General and administrative 1,352,197 916,237 3,978,798 3,392,056
Depreciation and amortization 288,576 305,864 897,479 771,030
Total operating expense 3,822,523 3,302,319 11,567,526 10,369,721
Income from operations 1,262,343 1,521,782 3,703,203 3,925,370
Other income (expense):        
Interest income 350,691 275,941 925,297 554,299
Interest expense (8,036) (9,771) (21,956) (52,481)
Unrealized gain (loss) on short term investments 5,429 35,068 48,071 (3,753)
Other gain 0 0 0 70,047
Income before income taxes 1,610,427 1,823,020 4,654,615 4,493,482
(Provision) for income taxes: (60,000) (160,000) (274,491) (280,006)
Net income 1,550,427 1,663,020 4,380,124 4,213,476
Dividends on preferred stock (134,345) (146,611) (427,567) (439,833)
Net income applicable to common shareholders $ 1,416,082 $ 1,516,409 $ 3,952,557 $ 3,773,643
Weighted average shares, basic (in shares) 18,194,000 18,394,000 18,194,000 18,408,000
Weighted average shares, diluted (in shares) 18,954,000 18,751,000 18,874,000 18,702,000
Basic income per share (in dollars per share) $ 0.08 $ 0.08 $ 0.22 $ 0.2
Diluted income per share (in dollars per share) $ 0.08 $ 0.08 $ 0.21 $ 0.2
Net income $ 1,550,427 $ 1,663,020 $ 4,380,124 $ 4,213,476
Unrealized loss on available-for-sale securities (25,102) 0 (31,006) 0
Total comprehensive income $ 1,525,325 $ 1,663,020 $ 4,349,118 $ 4,213,476
v3.24.1.1.u2
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 4,380,124 $ 4,213,476
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 897,479 771,030
Amortization of operating right of use asset 45,070 43,019
Stock compensation expense 260,853 315,216
Bad debt expense 225,000 1,200,000
(Increase) decrease in:    
Accounts receivables (1,439,014) 86,972
Long-term receivables, prepaids and other assets 751 655,391
Accounts payable 79,025 (309,812)
Operating lease liability (43,417) (39,777)
Accrued liabilities (58,391) 122,744
Deferred revenue 563,261 7,631
Net cash provided by operating activities 4,910,741 7,065,890
Cash flows from investing activities:    
Purchase of property and equipment (17,532) (133,944)
Capitalization of software costs (0) 769,243
Purchase of marketable securities 31,006 (0)
Net cash provided by (used in) investing activities (48,538) (903,187)
Cash flows from financing activities:    
Net (decrease) increase in lines of credit 0 (2,590,907)
Common stock buy-back/retirement (1,515,574) (981,194)
Redemption of series B-1 preferred (1,499,990) 0
Proceeds from employee stock plan 111,839 92,728
Dividends paid (1,286,657) (993,037)
Payments on notes payable and capital leases (210,020) (209,748)
Net cash used in financing activities (4,400,402) (4,682,158)
Net increase (decrease) in cash and cash equivalents 461,801 1,480,545
Cash and cash equivalents at beginning of period 23,990,879 21,460,948
Cash and cash equivalents at end of period 24,452,680 22,941,493
us-gaap_SupplementalCashFlowInformationAbstract    
Cash paid for income taxes 317,944 264,486
Cash paid for interest 11,711 52,481
Cash paid for operating leases 54,606 53,015
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Dividends accrued on preferred stock 427,567 439,833
Common Stock to Pay Accrued Liabilities [Member]    
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Common stock to pay accrued liabilities $ 445,980 $ 256,977
v3.24.1.1.u2
Consolidated Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Series B-1 Preferred Stock [Member]
Preferred Stock [Member]
Series B-1 Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance, March 31, 2024 (in shares) 625,375   212,402   18,460,538        
Balance, March 31, 2024 $ 6,254   $ 2,124   $ 184,608 $ 68,653,361 $ (25,943,287)   $ 42,903,060
Balance (in shares) at Jun. 30, 2022 625,375   212,402   18,460,538        
Balance at Jun. 30, 2022 $ 6,254   $ 2,124   $ 184,608 68,653,361 (25,943,287)   $ 42,903,060
Accrued compensation (in shares)         15,603       76,873
Accrued compensation         $ 156 76,717 0    
Employee stock plan (in shares)         13,064        
Employee stock plan         $ 131 48,772 0   $ 48,903
Stock buyback (in shares)         (20,859)        
Stock buyback         $ (209) (103,448) 0   (103,657)
Preferred Dividends-Declared         0 0 (146,611)   (146,611)
Common Stock Dividends-Declared         0 0 (277,162)   (277,162)
Net income         $ 0 0 1,285,112   $ 1,285,112
Accrued compensation (in shares)         15,603       76,873
Accrued compensation         $ 156 76,717 0    
Stock buyback         209 103,448 (0)   $ 103,657
Preferred Dividends-Declared         (0) (0) 146,611   146,611
Common Stock Dividends-Declared         $ (0) (0) 277,162   277,162
Balance (in shares) at Sep. 30, 2022 625,375   212,402   18,468,346        
Balance at Sep. 30, 2022 $ 6,254   $ 2,124   $ 184,686 68,675,402 (25,081,948)   43,786,518
Stock buyback (in shares)         20,859        
Balance (in shares) at Jun. 30, 2022 625,375   212,402   18,460,538        
Balance at Jun. 30, 2022 $ 6,254   $ 2,124   $ 184,608 68,653,361 (25,943,287)   42,903,060
Net income                 4,213,476
Balance (in shares) at Mar. 31, 2023 625,375   212,402   18,350,765        
Balance at Mar. 31, 2023 $ 6,254   $ 2,124   $ 183,510 68,022,970 (22,997,981)   45,216,877
Balance, March 31, 2024 (in shares) 625,375   212,402   18,468,346        
Balance, March 31, 2024 $ 6,254   $ 2,124   $ 184,686 68,675,402 (25,081,948)   43,786,518
Balance (in shares) at Sep. 30, 2022 625,375   212,402   18,468,346        
Balance at Sep. 30, 2022 $ 6,254   $ 2,124   $ 184,686 68,675,402 (25,081,948)   $ 43,786,518
Accrued compensation (in shares) 0   0   14,691       75,322
Accrued compensation $ 0   $ 0   $ 147 75,175 0    
Stock buyback (in shares) 0   0   (88,741)        
Stock buyback $ 0   $ 0   $ (888) (447,378) 0   $ (448,266)
Preferred Dividends-Declared 0   0   0 0 (146,611)   (146,611)
Common Stock Dividends-Declared         0 0 (275,914)   (275,914)
Net income $ 0   $ 0   $ 0 0 1,265,344   $ 1,265,344
Accrued compensation (in shares) 0   0   14,691       75,322
Accrued compensation $ 0   $ 0   $ 147 75,175 0    
Stock buyback (0)   (0)   888 447,378 (0)   $ 448,266
Preferred Dividends-Declared $ (0)   $ (0)   (0) (0) 146,611   146,611
Common Stock Dividends-Declared         $ (0) (0) 275,914   275,914
Balance (in shares) at Dec. 31, 2022 625,375   212,402   18,394,296        
Balance at Dec. 31, 2022 $ 6,254   $ 2,124   $ 183,945 68,303,199 (24,239,129)   44,256,393
Stock buyback (in shares) (0)   (0)   88,741        
Balance, March 31, 2024 (in shares) 625,375   212,402   18,394,296        
Balance, March 31, 2024 $ 6,254   $ 2,124   $ 183,945 68,303,199 $ (24,239,129)   44,256,393
Accrued compensation (in shares) 0   0   19,036   0    
Accrued compensation $ 0   $ 0   $ 190 104,592     104,782
Employee stock plan (in shares)         11,583        
Employee stock plan         $ 116 43,709 $ 0   43,825
Stock buyback (in shares)         (74,150)        
Stock buyback         $ (741) 428,530 0   (429,271)
Preferred Dividends-Declared         0 0 146,611   146,611
Common Stock Dividends-Declared         0 0 (275,261)   (275,261)
Net income     $ 0   $ 0 0 $ 1,663,020   1,663,020
Accrued compensation (in shares) 0   0   19,036   0    
Accrued compensation $ 0   $ 0   $ 190 104,592     104,782
Stock buyback         741 (428,530) $ 0   429,271
Preferred Dividends-Declared         0 0 (146,611)   (146,611)
Common Stock Dividends-Declared         $ 0 0 275,261   275,261
Balance (in shares) at Mar. 31, 2023 625,375   212,402   18,350,765        
Balance at Mar. 31, 2023 $ 6,254   $ 2,124   $ 183,510 68,022,970 (22,997,981)   45,216,877
Stock buyback (in shares)         74,150        
Balance, March 31, 2024 (in shares) 625,375   212,402   18,350,765        
Balance, March 31, 2024 $ 6,254   $ 2,124   $ 183,510 68,022,970 (22,997,981)   45,216,877
Balance, March 31, 2024 (in shares) 625,375   212,402   18,309,051        
Balance, March 31, 2024 $ 6,254   $ 2,124   $ 183,093 67,732,887 (22,042,427) $ 0 45,881,931
Balance (in shares) at Jun. 30, 2023 625,375   212,402   18,309,051        
Balance at Jun. 30, 2023 $ 6,254   $ 2,124   $ 183,093 67,732,887 (22,042,427) 0 45,881,931
Accrued compensation (in shares)         3,716        
Accrued compensation         $ 37 37,463 0 0 37,500
Employee stock plan (in shares)         13,326        
Employee stock plan         $ 133 57,610 0 0 $ 57,743
Stock buyback (in shares)         (155,025)       (155,025) [1]
Stock buyback         $ (1,550) (1,320,532) 0 0 $ (1,322,082)
Preferred Dividends-Declared         0 0 (146,611) 0 (146,611)
Common Stock Dividends-Declared         0 0 (272,566) 0 (272,566)
Net income         $ 0 0 1,378,548 0 1,378,548
Preferred stock redemption (in shares) [2]       0          
Accrued compensation (in shares)         3,716        
Accrued compensation         $ 37 37,463 0 0 37,500
Stock buyback         1,550 1,320,532 (0) (0) 1,322,082
Preferred stock redemption (in shares) [2]       0          
Preferred Dividends-Declared         (0) (0) 146,611 (0) 146,611
Common Stock Dividends-Declared         $ (0) (0) 272,566 (0) 272,566
Balance (in shares) at Sep. 30, 2023 625,375   212,402   18,171,068        
Balance at Sep. 30, 2023 $ 6,254   $ 2,124   $ 181,713 66,507,428 (21,083,056) 0 $ 45,614,463
Stock buyback (in shares)         155,025       155,025 [1]
Balance (in shares) at Jun. 30, 2023 625,375   212,402   18,309,051        
Balance at Jun. 30, 2023 $ 6,254   $ 2,124   $ 183,093 67,732,887 (22,042,427) 0 $ 45,881,931
Preferred stock redemption (in shares)   0              
Preferred stock redemption (in shares)   0              
Balance (in shares) at Dec. 31, 2023 625,375   142,309   18,158,730        
Balance at Dec. 31, 2023 $ 6,254   $ 1,423   $ 181,590 65,637,265 (20,078,137) (5,904) 45,742,491
Balance (in shares) at Jun. 30, 2023 625,375   212,402   18,309,051        
Balance at Jun. 30, 2023 $ 6,254   $ 2,124   $ 183,093 67,732,887 (22,042,427) 0 45,881,931
Net income                 4,380,124
Preferred stock redemption       $ (1,499,990)          
Preferred stock redemption       $ 1,499,990          
Balance (in shares) at Mar. 31, 2024 625,375   72,216   18,221,527        
Balance at Mar. 31, 2024 $ 6,254   $ 722   $ 182,218 65,277,419 (18,962,710) (31,006) 46,472,897
Balance, March 31, 2024 (in shares) 625,375   212,402   18,171,068        
Balance, March 31, 2024 $ 6,254   $ 2,124   $ 181,713 66,507,428 (21,083,056) 0 45,614,463
Balance (in shares) at Sep. 30, 2023 625,375   212,402   18,171,068        
Balance at Sep. 30, 2023 $ 6,254   $ 2,124   $ 181,713 66,507,428 (21,083,056) 0 45,614,463
Accrued compensation (in shares) 0   0   9,674        
Accrued compensation $ 0   $ 0   $ 97 72,403 0 0 72,500
Employee stock plan (in shares) 0   0   0        
Employee stock plan $ 0   $ 0   $ 0 0 0 0 $ 0
Stock buyback (in shares) 0   0   (22,012)       (22,012) [1]
Stock buyback $ 0   $ 0   $ (220) (193,272) 0 0 $ (193,492)
Preferred Dividends-Declared 0   0   0 0 (146,611) 0 (146,611)
Common Stock Dividends-Declared         0 0 (299,619) 0 (299,619)
Net income $ 0   $ 0   $ 0 0 1,451,149 0 1,451,149
Preferred stock redemption (in shares)     (70,093) (70,093) [2]          
Preferred stock redemption     $ (701)     (749,294) 0 0 (749,995)
Other comprehensive income (loss)             0 (5,904) (5,904)
Accrued compensation (in shares) 0   0   9,674        
Accrued compensation $ 0   $ 0   $ 97 72,403 0 0 72,500
Stock buyback (0)   $ (0)   220 193,272 (0) (0) 193,492
Preferred stock redemption (in shares)     70,093 70,093 [2]          
Preferred stock redemption     $ 701     749,294 (0) (0) 749,995
Preferred Dividends-Declared $ (0)   $ (0)   (0) (0) 146,611 (0) 146,611
Common Stock Dividends-Declared         $ (0) (0) 299,619 (0) 299,619
Balance (in shares) at Dec. 31, 2023 625,375   142,309   18,158,730        
Balance at Dec. 31, 2023 $ 6,254   $ 1,423   $ 181,590 65,637,265 (20,078,137) (5,904) $ 45,742,491
Stock buyback (in shares) (0)   (0)   22,012       22,012 [1]
Balance, March 31, 2024 (in shares) 625,375   142,309   18,158,730        
Balance, March 31, 2024 $ 6,254   $ 1,423   $ 181,590 65,637,265 (20,078,137) (5,904) $ 45,742,491
Accrued compensation (in shares)         56,488        
Accrued compensation         $ 565 335,415     335,980
Employee stock plan (in shares)         6,309        
Employee stock plan         $ 63 54,033     $ 54,096
Stock buyback (in shares)                 0
Stock buyback                 $ 0
Preferred Dividends-Declared             134,345   134,345
Common Stock Dividends-Declared             (300,655)   (300,655)
Net income             1,550,427   $ 1,550,427
Preferred stock redemption (in shares)     70,093 (70,093) [2]         (140,186)
Preferred stock redemption     $ 701     749,294     $ 749,995
Other comprehensive income (loss)               (25,102) (25,102)
Accrued compensation (in shares)         56,488        
Accrued compensation         $ 565 335,415     335,980
Stock buyback                 $ 0
Preferred stock redemption (in shares)     (70,093) 70,093 [2]         140,186
Preferred stock redemption     $ (701)     (749,294)     $ (749,995)
Preferred Dividends-Declared             (134,345)   (134,345)
Common Stock Dividends-Declared             300,655   300,655
Balance (in shares) at Mar. 31, 2024 625,375   72,216   18,221,527        
Balance at Mar. 31, 2024 $ 6,254   $ 722   $ 182,218 65,277,419 (18,962,710) (31,006) $ 46,472,897
Stock buyback (in shares)                 0
Balance, March 31, 2024 (in shares) 625,375   72,216   18,221,527        
Balance, March 31, 2024 $ 6,254   $ 722   $ 182,218 $ 65,277,419 $ (18,962,710) $ (31,006) $ 46,472,897
[1] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
[2] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
v3.24.1.1.u2
Note 1 - Overview of Operations and Basis for Presentation
 9 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]

NOTE 1.

OVERVIEW OF OPERATIONS AND BASIS FOR PRESENTATION

 

Overview

 

ReposiTrak, Inc., a Nevada corporation (“ReposiTrak”, “We”, “us”, “our” or the “Company”) is a Software-as-a-Service (“SaaS”) which operates a business-to-business (“B2B”) e-commerce, compliance & traceability, and supply chain management platform that partners with retailers, wholesalers, distributors and their product suppliers to (a) help them manage specific programs, such as out-of-stock management and scan-based trading; (b) reduce risk in their supply chain by managing compliance documents and data; ensure compliance with new regulatory requirements supporting traceability; and (c) improve product ordering and forecasting in order to accelerate sales, control risks, and improve supply chain efficiencies.

 

The Company’s services are grouped in three application suites:

 

 

1.

ReposiTrak Compliance Management (“Compliance”) solutions, which helps the Company’s customers vet suppliers and reduce a company’s potential regulatory, legal, and criminal risk from its supply chain partners by providing a way for them to ensure these suppliers are compliant with food safety regulations, such as the Food Safety Modernization Act of 2011 (“FSMA”);
     
 

2.

ReposiTrak Traceability Network (“Traceability” or “RTN”), which helps the Company’s customers comply with federal regulatory requirements of traceability and provides the lowest cost, easiest to use way to manage the capture and sharing of key data elements (“KDEs”) now required by Section 204d of FSMA 2011 as designated products move through the supply chain at each ‘event’ known as a ‘critical tracking event’ or “CTE”, which includes tracking from farm to shelf; and
     
 

3.

ReposiTrak Supply Chain Solutions (“Supply Chain”), which help the Company’s customers to more efficiently manage various interactions with their suppliers. In other words, it provides customers with greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their supply chain faster and more cost effectively, and it helps them to manage these relationships more efficiently, enhancing revenue while lowering working capital, labor costs and reducing waste.

 

The Company’s services are delivered though proprietary software products designed, developed, marketed, and supported by the Company. These products provide visibility and facilitate improved business processes among all key constituents in the supply chain, starting with the retailer and moving backwards to suppliers and eventually to raw material providers.

 

The Company provides cloud-based applications and services that address e-commerce, supply chain, food safety, compliance and traceability activities. The principal customers for the Company’s products are household name multi-store food retail chains and restaurants including their suppliers, branded food manufacturers, food wholesalers and distributors, and other food service businesses.

 

The Company has a hub and spoke business model. The Company is typically engaged by retailers and wholesalers (“Hubs”), which in turn require their suppliers (“Spokes”) to utilize the Company’s services.

 

On December 21, 2023, the Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc. The Company is incorporated in the State of Nevada and has two principal subsidiaries: PC Group, Inc., a Utah corporation (98.76% owned) (“PCG Utah”) and Park City Group, Inc., a Delaware corporation (100% owned) (“PCG Delaware” and together with PCG Utah, the “Subsidiaries”). All intercompany transactions and balances have been eliminated in the Company’s consolidated financial statements, which contain the operating results of the operations. The Company has no business operations separate from the operations conducted through its Subsidiaries.

 

The Company’s principal executive offices are located at 5282 South Commerce Drive, Suite D292, Murray, Utah 84107. Its telephone number is (435) 645-2000. Its website address is www.repositrak.com.

 

 

Basis of Financial Statement Presentation

 

The interim financial information of the Company as of March 31, 2024 and for the three and nine months ended March 31, 2024 is unaudited, and the balance sheet as of June 30, 2023 is derived from audited financial statements. The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial statements. Accordingly, they omit or condense notes and certain other information normally included in financial statements prepared in accordance with U.S. GAAP. The accounting policies followed for quarterly financial reporting conform with the accounting policies disclosed in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended June 30, 2023. In the opinion of management, all adjustments necessary for a fair presentation of the financial information for the interim periods reported have been made. All such adjustments are of a normal recurring nature. The results of operations for the nine months ended March 31, 2024 are not necessarily indicative of the results that can be expected for the fiscal year ending June 30, 2024. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended June 30, 2023.
v3.24.1.1.u2
Note 2 - Significant Accounting Policies
 9 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Significant Accounting Policies [Text Block]

NOTE 2.

SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

The financial statements presented herein reflect the consolidated financial position of ReposiTrak, Inc. and our subsidiaries. All inter-company transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that materially affect the amounts reported in the consolidated financial statements. Actual results could differ from these estimates. The methods, estimates, and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results it reports in its financial statements. The U.S. Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as those that are most important to the portrayal of the Company’s financial condition and results and require the Company to make its most difficult and subjective judgments, often because of the need to make estimates of matters that are inherently uncertain. Based on this definition, the Company’s most critical accounting policies include revenue recognition, goodwill, other long-lived asset valuations, income taxes, stock-based compensation, and capitalization of software development costs.

 

Revenue Recognition

 

The Company recognizes revenue as it transfers control of deliverables (products, solutions and services) to its customers in an amount reflecting the consideration to which it expects to be entitled. To recognize revenue, the Company applies the following five step approach: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied. The Company accounts for a contract based on the terms and conditions the parties agree to, if the contract has commercial substance and if collectability of consideration is probable. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience.

 

The Company may enter into arrangements that consist of multiple performance obligations. Such arrangements may include any combination of its deliverables. To the extent a contract includes multiple promised deliverables, the Company applies judgment to determine whether promised deliverables are capable of being distinct and are distinct in the context of the contract. If these criteria are not met, the promised deliverables are accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, the Company allocates consideration among the performance obligations based on their relative standalone selling price. Standalone selling price is the price at which the Company would sell a promised good or service separately to the customer. When not directly observable, the Company typically estimates standalone selling price by using the expected cost plus a margin approach. The Company typically establishes a standalone selling price range for its deliverables, which is reassessed on a periodic basis or when facts and circumstances change.

 

 

For performance obligations where control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The selection of the method to measure progress towards completion requires judgment and is based on the nature of the deliverables to be provided. Revenue related to fixed-price contracts for application development and systems integration services, consulting or other technology services is recognized as the service is performed using the output method, under which the total value of revenue is recognized based on each contract’s deliverable(s) as they are completed and when value is transferred to a customer. Revenue related to fixed-price application maintenance, testing and business process services is recognized based on our right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in FASB ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”), paragraph 606-10-55-18 (“ASC 606-10-55-18”).

 

If the Company’s invoicing is not consistent with the value delivered, revenue is recognized as the service is performed based on the method described above. The output method measures the results achieved and value transferred to a customer, which is updated as the project progresses to reflect the latest available information; such estimates and changes in estimates involve the use of judgment. The cumulative impact of any revision in estimates is reflected in the financial reporting period in which the change in estimate becomes known and any anticipated losses on contracts are recognized immediately. Revenue related to fixed-price hosting and infrastructure services is recognized based on the Company’s right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in ASC 606-10-55-18. If the Company’s invoicing is not consistent with value delivered, revenue is recognized on a straight-line basis unless revenue is earned and obligations are fulfilled in a different pattern. The revenue recognition method applied to the types of contracts described above provides the most faithful depiction of performance towards satisfaction of the Company’s performance obligations.

 

Revenue related to the Company’s software license arrangements that do not require significant modification or customization of the underlying software is recognized when the software is delivered as control is transferred at a point in time. For software license arrangements that require significant functionality enhancements or modification of the software, revenue for the software license and related services is recognized as the services are performed in accordance with the methods described above. In software hosting arrangements, the rights provided to the customer, such as ownership of a license, contract termination provisions and the feasibility of the client to operate the software, are considered in determining whether the arrangement includes a license or a service. Revenue related to software maintenance and support is generally recognized on a straight-line basis over the contract period.

 

Management expects that incremental commission fees paid as a result of obtaining a contract are recoverable and therefore the Company capitalized them as contract costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less.

 

Revenue related to transaction-based or volume-based contracts is recognized over the period the services are provided in a manner that corresponds with the value transferred to the customer to-date relative to the remaining services to be provided.

 

From time to time, the Company may enter into arrangements with third party suppliers to resell products or services. In such cases, the Company evaluates whether the Company is the principal (i.e., report revenue on a gross basis) or agent (i.e., report revenue on a net basis). In doing so, the Company first evaluates whether it controls the good or service before it is transferred to the customer. If the Company controls the good or service before it is transferred to the customer, the Company is the principal; if not, the Company is the agent. Determining whether the Company controls the good or service before it is transferred to the customer may require judgment.

 

The Company provides customers with assurance that the related deliverable will function as the parties intended because it complies with agreed-upon specifications. General updates or patch fixes are not considered an additional performance obligation in the contract.

 

Variable consideration is estimated using either the sum of probability weighted amounts in a range of possible consideration amounts (expected value), or the single most likely amount in a range of possible consideration amounts (most likely amount), depending on which method better predicts the amount of consideration to which we may be entitled. The Company includes in the transaction price variable consideration only to the extent it is probable that a significant reversal of revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company’s estimates of variable consideration and determination of whether to include estimated amounts in the transaction price may involve judgment and is based largely on an assessment of its anticipated performance and all information that is reasonably available to the Company.

 

 

The Company assesses the timing of the transfer of goods or services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, the Company does not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less. If the difference in timing arises for reasons other than the provision of finance to either the customer or us, no financing component is deemed to exist. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing its services, not to receive or provide financing from or to customers. The Company does not consider set up or transition fees paid upfront by its customers to represent a financing component, as such fees are required to encourage customer commitment to the project and protect us from early termination of the contract.

 

Trade Accounts Receivable and Contract Balances

 

We classify our right to consideration in exchange for deliverables as either a receivable or a contract asset (unbilled receivable). A receivable is a right to consideration that is unconditional (i.e. only the passage of time is required before payment is due). For example, we recognize a receivable for revenue related to our transaction or volume-based contracts when earned regardless of whether amounts have been billed. We present such receivables in trade accounts receivable, net in our consolidated statements of financial position at their net estimated realizable value. We maintain an allowance for doubtful accounts to provide for the estimated amount of receivables that may not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables, judgment, and other applicable factors.

 

A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented in current and other assets in our consolidated balance sheets and primarily relate to unbilled amounts on fixed-price contracts utilizing the output method of revenue recognition. The table below shows movements in contract assets:

 

   

Contract

assets

  

Balance – June 30, 2023

   $ 295,011  

Revenue recognized during the period but not billed

     -  

Amounts reclassified to accounts receivable

     (10,000

)

Other

     (29,439

)

Balance – March 31, 2024

   $ 255,572  (1)

 

 

(1)

Contract asset balances for March 31, 2024 include a current and a long-term contract asset of $147,520 and $108,052, respectively.

 

Our contract assets and liabilities are reported at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

The table below shows movements in the deferred revenue balances (current and noncurrent) for the period:

 

   

Contract

liability

  

Balance – June 30, 2023

   $ 1,903,001  

Amounts billed but not recognized as revenue

     1,767,483  

Revenue recognized related to the opening balance of deferred revenue

     (1,204,222

)

Balance – March 31, 2024

   $ 2,466,262  

 

Our contract assets and liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

 

Disaggregation of Revenue

 

The table below presents disaggregated revenue from contracts with customers by contract-type. We believe this disaggregation best depicts the nature, amount, timing and uncertainty of our revenue and cash flows that may be affected by industry, market, and other economic factors:

 

   

Three Months Ended

    

Nine months Ended

  
   

March 31,

    

March 31,

  
   

2024

    

2023

    

2024

    

2023

  
                                 

Recurring revenue – subscription and support services

   $ 5,078,866     $ 4,811,634     $ 15,250,302     $ 14,232,827  

Non-recurring revenue – setup and training services

     6,000       12,467       20,427       62,264  
    $ 5,084,866     $ 4,824,101     $ 15,270,729     $ 14,295,091  

 

Earnings Per Share

 

Basic net income per share of Common Stock (“Basic EPS”) excludes dilution and is computed by dividing net income applicable to Common Stockholders by the weighted average number of Common Stock outstanding during the period. Diluted net income per share of Common Stock (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue shares of Common Stock were exercised or converted into Common Stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an antidilutive effect on net income per share of Common Stock.

 

For the three and nine months ended March 31, 2024 and 2023, warrants to purchase 23,737 shares of our common stock at an exercise price of $10.00 per share were anti-dilutive and not included in the computation of diluted earnings per share because the exercise price of the options was greater than the average price of common stock for the quarter.

 

The following table presents the components of the computation of basic and diluted earnings per share for the periods indicated:

 

   

Three Months Ended

    

Nine months Ended

  
   

March 31,

    

March 31,

  
   

2024

    

2024

    

2023

    

2023

  

Numerator

                                

Net income applicable to common shareholders

   $ 1,416,082     $ 1,516,409     $ 3,952,557     $ 3,773,643  
                                 

Denominator

                                

Weighted average common shares outstanding, basic

     18,194,000       18,394,000       18,194,000       18,408,000  

Warrants to purchase Common Stock

     760,000       357,000       680,000       294,000  

Weighted average common shares outstanding, diluted

     18,954,000       18,751,000       18,874,000       18,702,000  
                                 

Net income per share

                                

Basic

   $ 0.08     $ 0.08     $ 0.22     $ 0.20  

Diluted

   $ 0.08     $ 0.08     $ 0.21     $ 0.20  

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform with the current year’s presentation. These reclassifications have no impact on the previously reported results.

 

 
v3.24.1.1.u2
Note 3 - Equity
 9 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Equity [Text Block]

NOTE 3.

EQUITY

 

Restricted Stock Units

  

Restricted

Stock Units

    

Weighted

Average
Grant Date
Fair Value

($/share)

  
                 

Outstanding at June 30, 2023

     907,451     $ 5.30  

Granted

     15,130       10.55  

Vested and issued

     (58,437

)

     5.66  

Forfeited

     -       -  

Outstanding at March 31, 2024

     864,144     $ 5.37  

 

As of March 31, 2024, there were zero restricted stock units outstanding that had vested but for which shares of Common Stock had not yet been issued pursuant to the terms of the applicable agreement.

 

As of March 31, 2024, there was approximately $4.6 million of unrecognized stock-based compensation obligations under our equity compensation plans. The stock-based compensation obligation is in connection with certain employment agreements which have a deferral option at the Board’s discretion. At the end of the deferral period, the stock-based compensation expense associated with the obligation is expected to be recognized on a straight-line basis over a period of three years.

 

Warrants

 

Outstanding warrants were issued in connection with private placements of the Company’s Common Stock and with the restructuring of the Series B Preferred that occurred in March of 2018. The following table summarizes information about fixed stock warrants outstanding at March 31, 2024:

 

Warrants Outstanding

at March 31, 2024

    

Warrants Exercisable

at March 31, 2024

  

Range of

exercise

prices

   

Number

Outstanding

    

Weighted

average

remaining
contractual

life (years)

    

Weighted

average

exercise price

    

Number

exercisable

    

Weighted

average

exercise price

  
$ 4.00       1,085,068       1.85     $ 4.00       1,085,068     $ 4.00  
$ 10.00       23,737       1.82     $ 10.00       23,737     $ 10.00  
          1,108,805       1.85     $ 4.13       1,108,805     $ 4.13  

 

During the quarter ended March 31, 2023, the Company’s Board of Directors approved the modification to extend the expiration dates of the Company’s existing January 26, 2023 and February 5, 2023 warrants by an additional three years. Accordingly, all the Company’s outstanding warrants have been extended and are anticipated to expire or be exercised on or before the quarter ending March 31, 2026.

 

Preferred Stock

 

The Company’s articles of incorporation currently authorize the issuance of up to 30,000,000 shares of ‘blank check’ preferred stock, par value $0.01 (“Preferred Stock”), with designations, rights, and preferences as may be determined from time to time by the Company’s Board of Directors, of which 700,000 shares are currently designated as Series B Preferred Stock (“Series B Preferred”) and 550,000 shares are designated as Series B-1 Preferred Stock (“Series B-1 Preferred”). Both classes of Series B Preferred Stock pay dividends at a rate of 7% per annum if paid by the Company in cash, or 9% if paid by the Company by the issuance of additional shares of Series B-1 Preferred, or Series B-1 Preferred, as applicable.

 

Preferred Redemption

 

Section 4 of the Company’s First Amended and Restated Certificate of Designation of the Relative Rights, Powers and Preferences of the Series B-1 Preferred Stock, as amended (the “Series B-1 COD”) provides the Company’s Board of Directors with the right to redeem any or all of the outstanding shares of the Company’s Series B-1 Preferred for a cash payment of $10.70 per share at any time upon providing the holders of Series B-1 Preferred at least ten days written notice that sets forth the date on which the redemption will occur (the “Redemption Notice”).

 

On August 29, 2023, the Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). The Preferred Redemption is to occur over the next three years from August 29, 2023.

 

 

As of March 31, 2024, a total of 625,375 shares of Series B Preferred and 72,216 shares of Series B-1 Preferred were issued and outstanding. Since inception, a total of 140,186 Preferred shares at the redemption price of $10.70 per share have been redeemed for a total of $1,499,990.

 

The following table provides information about the redemption and retirement of the Series B Preferred during the nine months ended March 31, 2024:

 

   

Series B Preferred

  

Period (1)

  

Total
Number of
Shares
Redeemed

    

Price Paid
Per Share

    

Dollars

Expended

by Period

under the

Preferred

Redemption

    

Remaining
Amount
Available
for Future
Preferred

Redemption

  

July 1, 2023 – September 30, 2023:

     -     $ 10.70     $ -     $    

October 1, 2023 – December 31, 2023:

     -     $ 10.70     $ -     $ 6,691,513  

January 1, 2024 – March 31, 2024:

     -     $ 10.70     $ -     $ 6,691,513  

Total

     -             $ -     $ 6,691,513  

 

The following table provides information about the redemption and retirement of the Series B-1 Preferred during the three months ended March 31, 2024:

 

   

Series B-1 Preferred

  

Period (1)

  

Total
Number of
Shares
Redeemed

    

Price Paid
Per Share

    

Dollars

Expended

by Period

under the

Preferred

Redemption

    

Remaining
Amount
Available
for Future
Preferred

Redemption

  

July 1, 2023 – September 30, 2023:

     -     $ 10.70     $ -     $    

October 1, 2023 – December 31, 2023:

     70,093     $ 10.70     $ 749,995     $ 1,522,706  

January 1, 2024 – March 31, 2024:

     70,093     $ 10.70     $ 749,995     $ 772,711  

Total

     140,186             $ 1,499,990     $ 772,711  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.

 

Share Repurchase Program

 

On May 9, 2019, our Board of Directors approved the repurchase of up to $4.0 million in shares of our Common Stock, which repurchases may be made in privately negotiated transactions or in the open market at prices per share not exceeding the then-current market prices (the “Share Repurchase Program”). Under the Share Repurchase Program, management has discretion to determine the dollar amount of shares to be repurchased and the timing of any repurchases in compliance with applicable laws and regulations, including Rule 10b-18 of the Exchange Act.

 

On March 17, 2020, the Board, given the extreme uncertainty due to COVID-19 at the time, suspended the Share Repurchase Program.

 

On May 18, 2021, our Board of Directors resumed its Share Repurchase Program, and increased the number of shares of Common Stock available to repurchase under the Share Repurchase Program by an additional $4 million bringing the total number of Common Stock authorized to repurchase under the Share Repurchase Program to $8.0 million.

 

On August 31, 2021, our Board of Directors approved a further increase to its Share Repurchase program to $12.0 million in shares of our Common Stock which added an additional $4 million to the Share Repurchase Program.

 

 

On May 10, 2022, our Board of Directors approved an increase of $9.0 million in the number of shares of Common Stock available to repurchase under the Share Repurchase Program.

 

Since inception of the Share Repurchase Program through March 31, 2024, a total of $21,000,000 in shares of Common Stock have been approved under the Share Repurchase Program, and 2,122,703 shares of Common Stock have been repurchased at an average purchase price of $6.13, resulting in $7,992,206 remaining available to repurchase under the current Share Repurchase Program. From time-to-time, our Board of Directors may authorize further increases to our Share Repurchase Program. In addition, the Share Repurchase Program may also be suspended for periods of time or discontinued at any time, at the Board’s discretion.

 

The following table provides information about repurchases of our Common Stock registered pursuant to Section 12 of the Exchange Act, during the three months ended March 31, 2024:

 

Period (1)

  

Total
Number of
Shares
Purchased

    

Average
Price Paid
Per Share

    

Dollars

Expended

by Period

Under the

Plans or
Programs

    

Remaining
Amount
Available
for Future
Share
Repurchases
Under the
Plans or
Programs

 

July 1, 2023 – September 30, 2023

     155,025     $ 8.53     $ 1,322,082     $ 8,185,698  

October 1, 2023 – December 31, 2023:

     22,012     $ 8.79     $ 193,492     $ 7,992,206  

January 1, 2024 – March 31, 2024:

     -     $ -     $ -     $ 7,992,206  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
v3.24.1.1.u2
Note 4 - Related Party Transactions
 9 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

NOTE 4.

RELATED PARTY TRANSACTIONS

 

During the nine months ended March 31, 2024, the Company continued to be a party to a service agreement (the “Service Agreement”) with Fields Management, Inc. (“FMI”), pursuant to which FMI provided certain executive management services to the Company, including designating Randall K. Fields to perform the functions of President and Chief Executive Officer for the Company. Mr. Fields, FMI’s designated executive, who also serves as the Company’s Chair of the Board of Directors, controls FMI. The Company had no payables to FMI under the Service Agreement as of March 31, 2024 or June 30, 2023. During the nine months ended March 31, 2024 and 2023, the Company paid FMI $727,352 and $693,045, respectively, in connection with the Service Agreement.

 

During the nine months ended March 31, 2024, the Company, the Company redeemed and retired $1,499,990 in Series B-1 Preferred from Mr. Randall K. Fields, affiliates of Mr. Fields, and Robert W. Allen. Mr. Allen is a director of the Company.
v3.24.1.1.u2
Note 5 - Recent Accounting Pronouncements
 9 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Accounting Standards Update and Change in Accounting Principle [Text Block]

NOTE 5.

RECENT ACCOUNTING PRONOUNCEMENTS

 

The Company has reviewed newly issued accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on its consolidated condensed financial statements as a result of future adoption.
v3.24.1.1.u2
Note 6 - Subsequent Events
 9 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Subsequent Events [Text Block]

NOTE 6.

SUBSEQUENT EVENTS

 

In accordance with the Subsequent Events Topic of the FASB ASC 855, we have evaluated subsequent events through the filing date and determined that no subsequent events occurred that were reasonably expected to impact the consolidated condensed financial statements presented herein.

 

 
v3.24.1.1.u2
Insider Trading Arrangements
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2024
Insider Trading Arr Line Items    
Material Terms of Trading Arrangement [Text Block]  

ITEM 5.

OTHER INFORMATION

 

None.
Rule 10b5-1 Arrangement Adopted [Flag] false  
Rule 10b5-1 Arrangement Terminated [Flag] false  
Non-Rule 10b5-1 Arrangement Adopted [Flag] false  
Non-Rule 10b5-1 Arrangement Terminated [Flag] false  
v3.24.1.1.u2
Significant Accounting Policies (Policies)
 9 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]

Principles of Consolidation

 

The financial statements presented herein reflect the consolidated financial position of ReposiTrak, Inc. and our subsidiaries. All inter-company transactions and balances have been eliminated in consolidation.

 
Use of Estimates, Policy [Policy Text Block]

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that materially affect the amounts reported in the consolidated financial statements. Actual results could differ from these estimates. The methods, estimates, and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results it reports in its financial statements. The U.S. Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as those that are most important to the portrayal of the Company’s financial condition and results and require the Company to make its most difficult and subjective judgments, often because of the need to make estimates of matters that are inherently uncertain. Based on this definition, the Company’s most critical accounting policies include revenue recognition, goodwill, other long-lived asset valuations, income taxes, stock-based compensation, and capitalization of software development costs.
Revenue [Policy Text Block]

Revenue Recognition

 

The Company recognizes revenue as it transfers control of deliverables (products, solutions and services) to its customers in an amount reflecting the consideration to which it expects to be entitled. To recognize revenue, the Company applies the following five step approach: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied. The Company accounts for a contract based on the terms and conditions the parties agree to, if the contract has commercial substance and if collectability of consideration is probable. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience.

 

The Company may enter into arrangements that consist of multiple performance obligations. Such arrangements may include any combination of its deliverables. To the extent a contract includes multiple promised deliverables, the Company applies judgment to determine whether promised deliverables are capable of being distinct and are distinct in the context of the contract. If these criteria are not met, the promised deliverables are accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, the Company allocates consideration among the performance obligations based on their relative standalone selling price. Standalone selling price is the price at which the Company would sell a promised good or service separately to the customer. When not directly observable, the Company typically estimates standalone selling price by using the expected cost plus a margin approach. The Company typically establishes a standalone selling price range for its deliverables, which is reassessed on a periodic basis or when facts and circumstances change.

 

 

For performance obligations where control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The selection of the method to measure progress towards completion requires judgment and is based on the nature of the deliverables to be provided. Revenue related to fixed-price contracts for application development and systems integration services, consulting or other technology services is recognized as the service is performed using the output method, under which the total value of revenue is recognized based on each contract’s deliverable(s) as they are completed and when value is transferred to a customer. Revenue related to fixed-price application maintenance, testing and business process services is recognized based on our right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in FASB ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”), paragraph 606-10-55-18 (“ASC 606-10-55-18”).

 

If the Company’s invoicing is not consistent with the value delivered, revenue is recognized as the service is performed based on the method described above. The output method measures the results achieved and value transferred to a customer, which is updated as the project progresses to reflect the latest available information; such estimates and changes in estimates involve the use of judgment. The cumulative impact of any revision in estimates is reflected in the financial reporting period in which the change in estimate becomes known and any anticipated losses on contracts are recognized immediately. Revenue related to fixed-price hosting and infrastructure services is recognized based on the Company’s right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in ASC 606-10-55-18. If the Company’s invoicing is not consistent with value delivered, revenue is recognized on a straight-line basis unless revenue is earned and obligations are fulfilled in a different pattern. The revenue recognition method applied to the types of contracts described above provides the most faithful depiction of performance towards satisfaction of the Company’s performance obligations.

 

Revenue related to the Company’s software license arrangements that do not require significant modification or customization of the underlying software is recognized when the software is delivered as control is transferred at a point in time. For software license arrangements that require significant functionality enhancements or modification of the software, revenue for the software license and related services is recognized as the services are performed in accordance with the methods described above. In software hosting arrangements, the rights provided to the customer, such as ownership of a license, contract termination provisions and the feasibility of the client to operate the software, are considered in determining whether the arrangement includes a license or a service. Revenue related to software maintenance and support is generally recognized on a straight-line basis over the contract period.

 

Management expects that incremental commission fees paid as a result of obtaining a contract are recoverable and therefore the Company capitalized them as contract costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less.

 

Revenue related to transaction-based or volume-based contracts is recognized over the period the services are provided in a manner that corresponds with the value transferred to the customer to-date relative to the remaining services to be provided.

 

From time to time, the Company may enter into arrangements with third party suppliers to resell products or services. In such cases, the Company evaluates whether the Company is the principal (i.e., report revenue on a gross basis) or agent (i.e., report revenue on a net basis). In doing so, the Company first evaluates whether it controls the good or service before it is transferred to the customer. If the Company controls the good or service before it is transferred to the customer, the Company is the principal; if not, the Company is the agent. Determining whether the Company controls the good or service before it is transferred to the customer may require judgment.

 

The Company provides customers with assurance that the related deliverable will function as the parties intended because it complies with agreed-upon specifications. General updates or patch fixes are not considered an additional performance obligation in the contract.

 

Variable consideration is estimated using either the sum of probability weighted amounts in a range of possible consideration amounts (expected value), or the single most likely amount in a range of possible consideration amounts (most likely amount), depending on which method better predicts the amount of consideration to which we may be entitled. The Company includes in the transaction price variable consideration only to the extent it is probable that a significant reversal of revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company’s estimates of variable consideration and determination of whether to include estimated amounts in the transaction price may involve judgment and is based largely on an assessment of its anticipated performance and all information that is reasonably available to the Company.

 

 

The Company assesses the timing of the transfer of goods or services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, the Company does not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less. If the difference in timing arises for reasons other than the provision of finance to either the customer or us, no financing component is deemed to exist. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing its services, not to receive or provide financing from or to customers. The Company does not consider set up or transition fees paid upfront by its customers to represent a financing component, as such fees are required to encourage customer commitment to the project and protect us from early termination of the contract.
Receivable [Policy Text Block]

Trade Accounts Receivable and Contract Balances

 

We classify our right to consideration in exchange for deliverables as either a receivable or a contract asset (unbilled receivable). A receivable is a right to consideration that is unconditional (i.e. only the passage of time is required before payment is due). For example, we recognize a receivable for revenue related to our transaction or volume-based contracts when earned regardless of whether amounts have been billed. We present such receivables in trade accounts receivable, net in our consolidated statements of financial position at their net estimated realizable value. We maintain an allowance for doubtful accounts to provide for the estimated amount of receivables that may not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables, judgment, and other applicable factors.

 

A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented in current and other assets in our consolidated balance sheets and primarily relate to unbilled amounts on fixed-price contracts utilizing the output method of revenue recognition. The table below shows movements in contract assets:

 

   

Contract

assets

  

Balance – June 30, 2023

   $ 295,011  

Revenue recognized during the period but not billed

     -  

Amounts reclassified to accounts receivable

     (10,000

)

Other

     (29,439

)

Balance – March 31, 2024

   $ 255,572  (1)

 

 

(1)

Contract asset balances for March 31, 2024 include a current and a long-term contract asset of $147,520 and $108,052, respectively.

 

Our contract assets and liabilities are reported at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

The table below shows movements in the deferred revenue balances (current and noncurrent) for the period:

 

   

Contract

liability

  

Balance – June 30, 2023

   $ 1,903,001  

Amounts billed but not recognized as revenue

     1,767,483  

Revenue recognized related to the opening balance of deferred revenue

     (1,204,222

)

Balance – March 31, 2024

   $ 2,466,262  

 

Our contract assets and liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 
Disaggregation of Revenue [Policy Text Block]

Disaggregation of Revenue

 

The table below presents disaggregated revenue from contracts with customers by contract-type. We believe this disaggregation best depicts the nature, amount, timing and uncertainty of our revenue and cash flows that may be affected by industry, market, and other economic factors:

 

   

Three Months Ended

    

Nine months Ended

  
   

March 31,

    

March 31,

  
   

2024

    

2023

    

2024

    

2023

  
                                 

Recurring revenue – subscription and support services

   $ 5,078,866     $ 4,811,634     $ 15,250,302     $ 14,232,827  

Non-recurring revenue – setup and training services

     6,000       12,467       20,427       62,264  
    $ 5,084,866     $ 4,824,101     $ 15,270,729     $ 14,295,091  

 
Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share

 

Basic net income per share of Common Stock (“Basic EPS”) excludes dilution and is computed by dividing net income applicable to Common Stockholders by the weighted average number of Common Stock outstanding during the period. Diluted net income per share of Common Stock (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue shares of Common Stock were exercised or converted into Common Stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an antidilutive effect on net income per share of Common Stock.

 

For the three and nine months ended March 31, 2024 and 2023, warrants to purchase 23,737 shares of our common stock at an exercise price of $10.00 per share were anti-dilutive and not included in the computation of diluted earnings per share because the exercise price of the options was greater than the average price of common stock for the quarter.

 

The following table presents the components of the computation of basic and diluted earnings per share for the periods indicated:

 

   

Three Months Ended

    

Nine months Ended

  
   

March 31,

    

March 31,

  
   

2024

    

2024

    

2023

    

2023

  

Numerator

                                

Net income applicable to common shareholders

   $ 1,416,082     $ 1,516,409     $ 3,952,557     $ 3,773,643  
                                 

Denominator

                                

Weighted average common shares outstanding, basic

     18,194,000       18,394,000       18,194,000       18,408,000  

Warrants to purchase Common Stock

     760,000       357,000       680,000       294,000  

Weighted average common shares outstanding, diluted

     18,954,000       18,751,000       18,874,000       18,702,000  
                                 

Net income per share

                                

Basic

   $ 0.08     $ 0.08     $ 0.22     $ 0.20  

Diluted

   $ 0.08     $ 0.08     $ 0.21     $ 0.20  

 
Reclassification [Policy Text Block]

Reclassifications

 

Certain prior year amounts have been reclassified to conform with the current year’s presentation. These reclassifications have no impact on the previously reported results.

 
v3.24.1.1.u2
Note 2 - Significant Accounting Policies (Tables)
 9 Months Ended
Mar. 31, 2024
Notes Tables  
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
   

Contract

assets

  

Balance – June 30, 2023

   $ 295,011  

Revenue recognized during the period but not billed

     -  

Amounts reclassified to accounts receivable

     (10,000

)

Other

     (29,439

)

Balance – March 31, 2024

   $ 255,572  (1)
   

Contract

liability

  

Balance – June 30, 2023

   $ 1,903,001  

Amounts billed but not recognized as revenue

     1,767,483  

Revenue recognized related to the opening balance of deferred revenue

     (1,204,222

)

Balance – March 31, 2024

   $ 2,466,262  
Disaggregation of Revenue [Table Text Block]
   

Three Months Ended

    

Nine months Ended

  
   

March 31,

    

March 31,

  
   

2024

    

2023

    

2024

    

2023

  
                                 

Recurring revenue – subscription and support services

   $ 5,078,866     $ 4,811,634     $ 15,250,302     $ 14,232,827  

Non-recurring revenue – setup and training services

     6,000       12,467       20,427       62,264  
    $ 5,084,866     $ 4,824,101     $ 15,270,729     $ 14,295,091  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

Three Months Ended

    

Nine months Ended

  
   

March 31,

    

March 31,

  
   

2024

    

2024

    

2023

    

2023

  

Numerator

                                

Net income applicable to common shareholders

   $ 1,416,082     $ 1,516,409     $ 3,952,557     $ 3,773,643  
                                 

Denominator

                                

Weighted average common shares outstanding, basic

     18,194,000       18,394,000       18,194,000       18,408,000  

Warrants to purchase Common Stock

     760,000       357,000       680,000       294,000  

Weighted average common shares outstanding, diluted

     18,954,000       18,751,000       18,874,000       18,702,000  
                                 

Net income per share

                                

Basic

   $ 0.08     $ 0.08     $ 0.22     $ 0.20  

Diluted

   $ 0.08     $ 0.08     $ 0.21     $ 0.20  
v3.24.1.1.u2
Note 3 - Equity (Tables)
 9 Months Ended
Mar. 31, 2024
Notes Tables  
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

Restricted Stock Units

  

Restricted

Stock Units

    

Weighted

Average
Grant Date
Fair Value

($/share)

  
                 

Outstanding at June 30, 2023

     907,451     $ 5.30  

Granted

     15,130       10.55  

Vested and issued

     (58,437

)

     5.66  

Forfeited

     -       -  

Outstanding at March 31, 2024

     864,144     $ 5.37  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Warrants Outstanding

at March 31, 2024

    

Warrants Exercisable

at March 31, 2024

  

Range of

exercise

prices

   

Number

Outstanding

    

Weighted

average

remaining
contractual

life (years)

    

Weighted

average

exercise price

    

Number

exercisable

    

Weighted

average

exercise price

  
$ 4.00       1,085,068       1.85     $ 4.00       1,085,068     $ 4.00  
$ 10.00       23,737       1.82     $ 10.00       23,737     $ 10.00  
          1,108,805       1.85     $ 4.13       1,108,805     $ 4.13  
Preferred Stock Redemption [Table Text Block]
   

Series B Preferred

  

Period (1)

  

Total
Number of
Shares
Redeemed

    

Price Paid
Per Share

    

Dollars

Expended

by Period

under the

Preferred

Redemption

    

Remaining
Amount
Available
for Future
Preferred

Redemption

  

July 1, 2023 – September 30, 2023:

     -     $ 10.70     $ -     $    

October 1, 2023 – December 31, 2023:

     -     $ 10.70     $ -     $ 6,691,513  

January 1, 2024 – March 31, 2024:

     -     $ 10.70     $ -     $ 6,691,513  

Total

     -             $ -     $ 6,691,513  
Share Repurchase Program [Table Text Block]
   

Series B-1 Preferred

  

Period (1)

  

Total
Number of
Shares
Redeemed

    

Price Paid
Per Share

    

Dollars

Expended

by Period

under the

Preferred

Redemption

    

Remaining
Amount
Available
for Future
Preferred

Redemption

  

July 1, 2023 – September 30, 2023:

     -     $ 10.70     $ -     $    

October 1, 2023 – December 31, 2023:

     70,093     $ 10.70     $ 749,995     $ 1,522,706  

January 1, 2024 – March 31, 2024:

     70,093     $ 10.70     $ 749,995     $ 772,711  

Total

     140,186             $ 1,499,990     $ 772,711  

Period (1)

  

Total
Number of
Shares
Purchased

    

Average
Price Paid
Per Share

    

Dollars

Expended

by Period

Under the

Plans or
Programs

    

Remaining
Amount
Available
for Future
Share
Repurchases
Under the
Plans or
Programs

 

July 1, 2023 – September 30, 2023

     155,025     $ 8.53     $ 1,322,082     $ 8,185,698  

October 1, 2023 – December 31, 2023:

     22,012     $ 8.79     $ 193,492     $ 7,992,206  

January 1, 2024 – March 31, 2024:

     -     $ -     $ -     $ 7,992,206  
v3.24.1.1.u2
Note 2 - Significant Accounting Policies (Details Textual) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Contract with Customer, Asset, after Allowance for Credit Loss, Current $ 147,520   $ 186,959
Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent $ 108,052   $ 108,052
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 23,737 23,737  
Maximum [Member]      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) $ 10 $ 10  
v3.24.1.1.u2
Note 2 - Significant Accounting Policies - Contract with Customer assets and liabilities (Details)
 9 Months Ended
Mar. 31, 2024
USD ($)
Balance $ 295,011
Balance 1,903,001
Revenue recognized during the period but not billed 0
Amounts billed but not recognized as revenue 1,767,483
Amounts reclassified to accounts receivable (10,000)
Revenue recognized related to the opening balance of deferred revenue (1,204,222)
Other (29,439)
Balance 2,466,262
Balance $ 255,572 [1]
[1] Contract asset balances for March 31, 2024 include a current and a long-term contract asset of $147,520 and $108,052, respectively.
v3.24.1.1.u2
Note 2 - Significant Accounting Policies - Schedule of Disaggregation of Revenue (Details) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Revenue $ 5,084,866 $ 4,824,101 $ 15,270,729 $ 14,295,091
Revenue 5,084,866 4,824,101 15,270,729 14,295,091
Subscription and Support [Member]        
Revenue 5,078,866 4,811,634 15,250,302 14,232,827
Revenue 5,078,866 4,811,634 15,250,302 14,232,827
Professional Services [Member]        
Revenue 6,000 12,467 20,427 62,264
Revenue $ 6,000 $ 12,467 $ 20,427 $ 62,264
v3.24.1.1.u2
Note 2 - Significant Accounting Policies - Schedule of Earnings Per Share (Details) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Net income applicable to common shareholders $ 1,416,082 $ 1,516,409 $ 3,952,557 $ 3,773,643
Weighted average shares, basic (in shares) 18,194,000 18,394,000 18,194,000 18,408,000
Warrants to purchase Common Stock (in shares) 760,000 357,000 680,000 294,000
Weighted average shares, diluted (in shares) 18,954,000 18,751,000 18,874,000 18,702,000
Basic (in dollars per share) $ 0.08 $ 0.08 $ 0.22 $ 0.2
Diluted (in dollars per share) $ 0.08 $ 0.08 $ 0.21 $ 0.2
v3.24.1.1.u2
Note 3 - Equity (Details Textual) - USD ($)
 3 Months Ended 6 Months Ended 58 Months Ended 147 Months Ended
May 10, 2022
Aug. 31, 2021
May 18, 2021
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2024
Aug. 29, 2023
Jun. 30, 2023
May 09, 2019
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount       $ 4,600,000       $ 4,600,000 $ 4,600,000      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)       3 years                
Preferred Stock, Shares Authorized (in shares)         30,000,000   30,000,000       30,000,000  
Preferred Stock, Par or Stated Value Per Share (in dollars per share)       $ 0.01       $ 0.01 $ 0.01   $ 0.01  
Preferred Stock, Redemption Price Per Share (in dollars per share)       $ 10.7       $ 10.7 $ 10.7 $ 10.7    
Preferred Stock, Redemption, Aggerate Purchase Price                   $ 8,964,214    
Preferred Stock, Redemption, Number of Shares Redeemed (in shares)       140,186         140,186      
Preferred Stock Redemption, Redeemed Amount                 $ 1,499,990      
Stock Repurchase Program, Authorized Amount   $ 12,000,000 $ 8,000,000 $ 21,000,000,000,000       $ 21,000,000,000,000 21,000,000,000,000     $ 4,000,000
Stock Repurchase Program, Increase in Authorized Amount $ 9,000,000 $ 4,000,000 $ 4,000,000                  
Stock Repurchased During Period, Shares (in shares)       0 22,012 [1] 155,025 [1]   2,122,703        
Shares Acquired, Average Cost Per Share       $ 0 $ 8.79 [1] $ 8.53 [1]   $ 6.13        
Share Repurchase Program, Remaining Authorized, Amount       $ 7,992,206       $ 7,992,206 $ 7,992,206      
Blank Check [Member]                        
Preferred Stock, Shares Authorized (in shares)       30,000,000       30,000,000 30,000,000      
Preferred Stock, Par or Stated Value Per Share (in dollars per share)       $ 0.01       $ 0.01 $ 0.01      
Series B Preferred Stock [Member]                        
Preferred Stock, Shares Authorized (in shares)       700,000       700,000 700,000   700,000  
Preferred Stock, Shares, Number (in shares)       700,000                
Preferred Stock, Redemption Price Per Share (in dollars per share)       $ 10.7       $ 10.7 $ 10.7      
Preferred Stock, Redemption, Aggerate Purchase Price       $ 6,691,513 $ 6,691,513   $ 6,691,513 $ 6,691,513 $ 6,691,513      
Preferred Stock, Shares Issued (in shares)       625,375       625,375 625,375   625,375  
Preferred Stock, Redemption, Number of Shares Redeemed (in shares)             0          
Series B-1 Preferred Stock [Member]                        
Preferred Stock, Shares Authorized (in shares)       550,000       550,000 550,000   550,000  
Preferred Stock, Shares, Number (in shares)       550,000                
Preferred Stock, Cash, Dividend Rate, Percentage       7.00%                
Preferred Stock, Series B Preferred Shares, Dividend Rate, Percentage       9.00%                
Preferred Stock, Redemption Price Per Share (in dollars per share) [2]       $ 10.7 $ 10.7 $ 10.7 $ 10.7 $ 10.7 $ 10.7      
Preferred Stock, Redemption, Aggerate Purchase Price [2]       $ 772,711 $ 1,522,706   $ 1,522,706 $ 772,711 $ 772,711      
Preferred Stock, Shares Issued (in shares)       72,216       72,216 72,216   212,402  
Preferred Stock, Redemption, Number of Shares Redeemed (in shares) [2]       70,093 70,093 0            
Restricted Stock Units (RSUs) [Member] | Vested and Unissued [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number (in shares)       0       0 0      
[1] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
[2] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
v3.24.1.1.u2
Note 3 - Equity - Schedule of Restricted Stock Units (Details) - Share-Based Payment Arrangement, Nonemployee [Member]
 3 Months Ended
Mar. 31, 2024
$ / shares
shares
Granted (in shares) | shares 15,130
Restricted Stock [Member]  
Outstanding (in shares) | shares 907,451
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares $ 5.3
Restricted Stock Units (RSUs) [Member]  
Granted, weighted average grant date fair value (in dollars per share) | $ / shares $ 10.55
Vested and issued (in shares) | shares (58,437)
Vested and issued, weighted average grant date fair value (in dollars per share) | $ / shares $ 5.66
Forfeited (in shares) | shares 0
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares $ 0
Outstanding (in shares) | shares 864,144
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares $ 5.37
v3.24.1.1.u2
Note 3 - Equity - Schedule of Warrants (Details)
 3 Months Ended
Mar. 31, 2024
$ / shares
shares
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 4.13
Class of Warrant or Right, Outstanding (in shares) | shares 1,108,805
Class of Warrant or Right, Weighted Average Remaining Contractual Term (Year) 1 year 10 months 6 days
Class of Warrant or Right, Warrants, Exercisable, Number (in shares) | shares 1,108,805
Class of Warrant or Right, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 4.13
Exercise Price, Four Dollars, Minimum [Member]  
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 4
Class of Warrant or Right, Outstanding (in shares) | shares 1,085,068
Class of Warrant or Right, Weighted Average Remaining Contractual Term (Year) 1 year 10 months 6 days
Class of Warrant or Right, Warrants, Exercisable, Number (in shares) | shares 1,085,068
Class of Warrant or Right, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 4
Exercise Price, Ten Dollars, Maximum [Member]  
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 10
Class of Warrant or Right, Outstanding (in shares) | shares 23,737
Class of Warrant or Right, Weighted Average Remaining Contractual Term (Year) 1 year 9 months 25 days
Class of Warrant or Right, Warrants, Exercisable, Number (in shares) | shares 23,737
Class of Warrant or Right, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 10
v3.24.1.1.u2
Note 3 - Equity - Preferred Stock Redemption (Details) - USD ($)
 3 Months Ended 6 Months Ended 147 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Aug. 29, 2023
Preferred stock redemption (in shares) 140,186       140,186  
Price paid per share (in dollars per share) $ 10.7       $ 10.7 $ 10.7
Dollars Expended by Period under the Preferred Redemption $ 1,499,990       $ 1,499,990  
Preferred Stock, Redemption, Aggerate Purchase Price           $ 8,964,214
Series B and Series B-1 Preferred Stock [Member]            
Preferred stock redemption (in shares)   0 0      
Price paid per share (in dollars per share)   $ 10.7 $ 10.7 $ 10.7    
Dollars Expended by Period under the Preferred Redemption   $ 0 $ 0 $ 0    
Preferred Stock, Redemption, Aggerate Purchase Price   6,691,513   $ 6,691,513    
Series B Preferred Stock [Member]            
Preferred stock redemption (in shares)       0    
Price paid per share (in dollars per share) $ 10.7       $ 10.7  
Dollars Expended by Period under the Preferred Redemption   0   $ 0    
Preferred Stock, Redemption, Aggerate Purchase Price $ 6,691,513 $ 6,691,513   $ 6,691,513 $ 6,691,513  
v3.24.1.1.u2
Note 3 - Equity - Shares Repurchase Program (Details) - USD ($)
 3 Months Ended 58 Months Ended 147 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2024
Mar. 31, 2024
Aug. 29, 2023
Preferred stock redemption (in shares) 140,186       140,186  
Stock buyback (in shares) 0 22,012 [1] 155,025 [1] 2,122,703    
Price paid per share (in dollars per share) $ 10.7     $ 10.7 $ 10.7 $ 10.7
July 1, 2023 – September 30, 2023 (in dollars per share) $ 0 $ 8.79 [1] $ 8.53 [1] $ 6.13    
Dollars Expended by Period under the Preferred Redemption $ 1,499,990     $ 1,499,990 $ 1,499,990  
July 1, 2023 – September 30, 2023 $ 7,992,206     $ 7,992,206 $ 7,992,206  
Preferred Stock, Redemption, Aggerate Purchase Price           $ 8,964,214
Share Repurchase Program [Member]            
Stock buyback (in shares) [1]   193,492 1,322,082      
July 1, 2023 – September 30, 2023 [1]   $ 7,992,206 $ 8,185,698      
Series B-1 Preferred Stock [Member]            
Preferred stock redemption (in shares) [2] 70,093 70,093 0      
Price paid per share (in dollars per share) [2] $ 10.7 $ 10.7 $ 10.7 $ 10.7 $ 10.7  
Dollars Expended by Period under the Preferred Redemption [2] $ 749,995 $ 749,995 $ 0 $ 749,995 $ 749,995  
Preferred Stock, Redemption, Aggerate Purchase Price [2] $ 772,711 $ 1,522,706   $ 772,711 $ 772,711  
[1] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
[2] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
v3.24.1.1.u2
Note 4 - Related Party Transactions (Details Textual) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Preferred Stock Value Redemption Amount $ (749,995) $ 749,995      
Series B-1 Preferred Stock [Member]          
Preferred Stock Value Redemption Amount     $ 1,499,990    
Related Party [Member]          
Accounts Payable $ 0   0   $ 0
FMI [Member] | Service Agreements [Member]          
Related Party Transaction, Amounts of Transaction     $ 727,352 $ 693,045  
ReposiTrak (NYSE:TRAK)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more ReposiTrak Charts.
ReposiTrak (NYSE:TRAK)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more ReposiTrak Charts.